NETWORK TOPOLOGY IN HUMAN PROTEIN INTERACTION DATA PREDICTS FUNCTIONAL ASSOCIATION by LI, HUA
Texas Medical Center Library
DigitalCommons@The Texas Medical Center
UT GSBS Dissertations and Theses (Open Access) Graduate School of Biomedical Sciences
12-2010
NETWORK TOPOLOGY IN HUMAN
PROTEIN INTERACTION DATA PREDICTS
FUNCTIONAL ASSOCIATION
HUA LI
Follow this and additional works at: http://digitalcommons.library.tmc.edu/utgsbs_dissertations
Part of the Bioinformatics Commons
This Dissertation (PhD) is brought to you for free and open access by the
Graduate School of Biomedical Sciences at DigitalCommons@The Texas
Medical Center. It has been accepted for inclusion in UT GSBS
Dissertations and Theses (Open Access) by an authorized administrator of
DigitalCommons@The Texas Medical Center. For more information,
please contact laurel.sanders@library.tmc.edu.
Recommended Citation
LI, HUA, "NETWORK TOPOLOGY IN HUMAN PROTEIN INTERACTION DATA PREDICTS FUNCTIONAL
ASSOCIATION" (2010). UT GSBS Dissertations and Theses (Open Access). Paper 93.
 - 1 - 
 
 
 
 
 
 
 
 
 
 
CHAPTER 1 
INTRODUCTION 
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Biological Networks are Highly Complex Networks Governed by Universal 
Laws 
 In the past century, traditional biology study focused on individual molecules has 
been a great success on discovering their cellular functions. From genomic sequences to 
protein structures and beyond, we have already collected unprecedented amount of 
information on various species, including Homo sapiens. It has been increasingly realized 
that most biological functions are not carried out by merely a single molecule; instead, they 
always come from very complex interactions of different cellular constituents (e.g. DNA, 
RNA, proteins) which form a highly sophisticated network [1-9]. Therefore, it becomes a 
very prevailing idea to treat living cells as a complex network which shares many common 
characteristics of other networks, such as Internet and social network. 
 Biological networks, at a highly abstract level, can be reduced to a simple graph with 
nodes representing its components and links representing the interactions between any two 
components. Examples include biological networks [10-11], social networks [12-15] and 
technological networks [16-18]. Biological networks can be either directed or undirected 
depending on the nature of interaction. For example, gene regulatory networks are always 
considered as directed networks because regulatory interaction causes changes in the 
expression of target genes. By contrast, protein interaction networks are undirected since the 
interactions do not have any assigned direction [9]. 
 In 1960, Paul Erdos and Alfred Renyi proposed a model of the random network and 
studied its mathematical properties [19]. In the model, they assumed that a fixed number of 
nodes are randomly connected to each other (i.e. edges are placed randomly among nodes); in 
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other words, each node has the same probability to be connected by other nodes. In this type 
of network, the degrees of nodes follow a Poisson distribution, which means it‘s very hard to 
observe nodes with significant larger or smaller degree than the average degree of the 
network [9].  
 After a series of studies focused on the real networks, such as biological networks and 
social networks, topological properties were found be to be different from what was proposed 
in the random network [19]. Instead of the Poisson degree distribution, the degrees of nodes 
actually follow a power-law distribution in most real networks, which means the probability 
that a node has k links follows 𝑃(𝑘)~𝑘−γ (γ is the degree exponent with values being 
between 2 and 3 in most cases) [9, 20]. Networks with a power-law degree distribution are 
called scale-free networks, where most nodes only have a few link and they are connected to 
so-called ―hub‖ nodes that have a large number of connectivity in the network [20]. In such a 
network, hubs play a much more important role than those with only a few links, which is 
totally different from the random network. 
 Most networks in living cells approximate a scale-free topology, including protein- 
protein interaction (PPI) networks. In several recent publications, PPI networks have been 
shown to be scale free in many eukaryotic species, including human [21-27]. For example, 
the scale-free topology is obvious in a human PPI network (Fig. 1) which shows that most 
proteins have only a few direct interacting neighbors, while hub proteins have significantly 
more neighbors.  
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High-throughput Screening Enables Mapping of Protein-Protein 
Interaction Networks on a Large Scale 
 Due to technological advances on DNA sequencing, biologists are now discovering 
novel genes at an unprecedented speed, which makes it a more challenging and important 
task to annotate genes‘ functions [76]. Large-scale mapping of PPI data by high-throughput 
screenings is one significant step for accomplishing this task, which enables very fast 
assignment of functional annotations by network-based annotating schemes and algorithms 
[76]. So far, two methods have been widely used to generate large-scale PPI maps: yeast 
two-hybrid (Y2H) and co-affinity purification followed by mass spectrometry [25, 26, 
28-33].  
Y2H screens use mating assays illustrated in Fig. 2: proteins needs to be tested for 
interactions will be expressed as hybrid fusion proteins in yeast [34-36]. In Fig. 2a, protein X 
is fused to a DNA-binding domain (BD) of a transcription factor (TF) which will later bind to 
the upstream of a reporter gene. Protein Y is fused to a transcription activation domain (AD). 
If Protein X and Y interact with each other, the TF (usually Gal4 or LexA) will have the 
function of activation on the reporter gene. Since reporter genes are always required for yeast 
to grow, only yeasts with the interaction of X and Y will form a colony on media. In some 
cases, LacZ is used as a reporter whose activity can be detected by blue color on indicator 
plates. In order to test which AD strains a BD strain may have interaction with, the BD strain 
is mated to an array of AD strains which effectively tests the BD strain against each AD strain 
in the array (Fig. 2b). To test a large amount of BD strains against AD strains, libraries of AD 
strains are retrieved from cDNA or pools of AD arrays, and then individual BD strains are 
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mated with the libraries of AD strains. Clones with reporters activated will survive in the 
media and be picked for sequencing (Fig. 2c). [36-41] 
Affinity purification followed by mass spectrometry allows identification of 
interacting partners [42]. This technology has been used to explore the relationships between 
proteins because it allows rapid characterization of any protein present in a complex mixture 
as long as the complex is purified sufficiently and has enough quantity [42-46]. With the help 
of complete genome sequencing of several species, proteins can now be identified by mass 
spectrometry more conveniently [42]. Not only has Affinity purification been used to 
generate large-scale PPI networks [31, 32], but also has been an independent approach to 
valid the PPIs obtained from Y2H screens [23]. 
 
Network-based Prediction Schemes have been Widely Used to Predict 
Protein Functions 
To date, PPI networks for several organisms, including human, have been mapped 
partially [23-26, 49-54]. These PPI networks are valuable resources which provide many new 
insights into protein functions. From a system biology point of view, compiling PPI networks 
are also very important as they may help to uncover the underlying organization principles of 
cellular networks when times and locations for PPIs are taken into consideration [24, 55]. For 
this reason, different algorithms and methods have been formulated to investigate these 
networks, trying to figure out protein functions [56-71] and their roles in diseases [72-74]. 
However, due to notorious noises present in the process of high-through put data generation 
[47, 48], it now becomes critical to develop algorithms which reduce influence of these 
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noises and improve the overall quality of our functional inferences [76].  
The large volume of PPI data in the recent decade has presented the opportunity to 
systematically analyze the topology of PPI networks and develop network-based statistics for 
large-scale functional prediction. One popular method to suggest biological function is to 
compare real PPI networks with similar random networks (i.e. random networks with the 
same degree distribution) to find unusual topological connectivity among proteins. Typically, 
if two proteins share an unusual large number of common neighbors, functional association 
between the two proteins may be claimed [75]. Here we call this method ―common-neighbor 
statistics‖. Such statistics has been used to assess the functional relationship between proteins 
in a yeast PPI network, and functional predictions based on statistical significance have been 
made from these relationships [75, 76].  
 
Common-neighbor statistics can be further improved to provide better 
functional prediction 
 Lots of evidences showed that such human PPI network is nonrandom with respect to 
its network topology [27, 33, 75, 76, 78]. Here we assumed that most of the nonrandomness 
is necessary for human PPI networks to perform proper biological functions. We further 
hypothesize that, in human PPI networks, if two proteins share a number of interacting 
neighbors which is significantly larger than that occurred on average in randomized scale-free 
networks (i.e. random networks with the same degree distribution as human PPI networks), 
the two proteins are more likely to share a common or related biological function. In prior 
work on yeast PPI network, Samanta and Liang (2003) developed an algorithm (i.e. 
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common-neighbor statistics) to rank the nonrandomness of network topology, and hence the 
functional associations between proteins [75]. In this dissertation, we developed an additional 
algorithm to overcome a deficiency in their previous work and make the ranking more 
accurate [76]. We found that the combination of these two algorithms lead to better ranking 
of protein functional associations, thereby enhancing the overall quality of functional 
inferences. We applied our method to a comprehensive human PPI data set which is publicly 
available from www.thebiogrid.com [77]. We also developed a clustering method to analyze 
protein functions and pathways systematically. With the clustering method, we built a cluster 
consisting of 1729 proteins and we found most functionally related proteins stayed together 
in the cluster [76]. After cutting the cluster into subclusters, we performed pathway analysis 
and identified many subclusters significantly enriched in different signaling pathways [76]. In 
particular, we made an in-depth analysis of the transforming growth factor β (TGF-β) 
pathway which is important in cell proliferation and tumorigenesis, and suggested a list of 
proteins presumably involved in several signaling pathways [76]. 
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Figure 1 A graph of the human PPI network involving 401 proteins and 911 interactions 
[26]. The color of nodes represents proteins‘ annotation status: Orange: disease proteins 
(according to OMIM morbidmap, NCBI); light blue: proteins with GO annotation; yellow: 
proteins without GO and disease annotation. The color of links between proteins represents 
the confidence score of interactions: Green: 3 quality points; blue: 4 quality points; red: 5 
quality points; purple: 6 quality points (the high the score is, the more reliable the interaction 
is). All links here were considered high-confidence interactions (see Ref 24 for more details). 
Fig. 1 was reproduced with permission from REF. 24. 
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Figure 2 Yeast two-hybrid screening methods. (a) The basic idea of high-throughput Y2H 
screening. After yeast mating, the expression plasmids from two different haploid yeast 
strains are brought together. In the first strain, protein X is fused to a DNA-binding domain 
(BD) and will bind the upstream of the reporter gene. A transcription activation domain (AD) 
which is fused to protein Y in the second strain will activate the expression of the reporter 
gene after mating of the two strains if protein X and Y interact with each other. After the 
reporter gene is expressed, election can be made on media. (b) The basic idea of matrix 
approach for testing a single BD strain against each AD strain on the array. (c) The basic idea 
of library approach for testing single or multiple BD strains against libraries of AD strains. 
Fig.2 was reproduced with permission from REF 36. 
  
 - 10 - 
 
 
 
 
 
 
 
 
 
CHAPTER 2 
RESULTS 
 
 
 
 
 
 
 
 
 
 
 
  
 - 11 - 
 
Our human PPI network is a scale-free network 
 The degree k (or connectivity) of a node shows how the number of links it has 
connected to other nodes in a network. In human PPI networks, recent publications have 
shown that the degree distribution approximates a power law, 𝑃(𝑘)~𝑘−γ, where γ is the 
degree exponent. For our human PPI network (7,362 nodes with 20,019 links), the degree k 
also follows a power-law distribution, where the exponent γ is 1.93 (Fig. 3). 
 
 
Figure 3 The degree distribution of our human PPI network. Here k represents the degree 
of node, P(k) gives the probability that a node has k links. Data were plotted in linear-linear 
scale (a) and log-log scale (b). In (b), the solid black line was fitted with simple linear 
regression (R
2
 = 0.93, P < 2.2e-16); it has a slope of -1.93 (P < 2e-16). Thus, the exponent γ 
is 1.93 in the power-law degree distribution for our human PPI network.  
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The Derivation of Algorithm I and II 
 Suppose that we have a random PPI network of size N. The total number of edges 
(interactions) is pre-determined, and edges randomly connect nodes (interacting neighbors) 
with an equal probability. This specifies a random network same as what was proposed in 
REF. 19.  If we randomly choose two proteins, X and Y (X has Xn  interacting neighbors 
and Y has Yn  interacting neighbors), and we find that X and Y share m  (m ≥ 0) common 
interacting neighbors in the random PPI network. Here we denote the set of common 
neighbors as },......,{ 21 mZZZ , the set of all proteins as },......,2,1{ ND , and the number 
of interacting partners for each protein in D  as },......,{ 21 Nnnn  
[76]. The sample space 
Ω consists of all the graphs (outcomes) that X and Y randomly connect Xn  and Yn  
proteins in the network, and we calculate the probability of the event that X and Y share m 
common neighbors. 
 Suppose that protein X randomly connects neighbors with an equal probability which 
only depends on the degree of X (the same for protein Y), then all possible graphs have the 
same probability to happen. The total number of possible graphs in which X and Y have m 
common partners is a product of three terms: (i) 
)!(!
!
mNm
N
m
N






  i.e., all possible ways to 
choose m proteins from N proteins without replacement; (ii) 








mn
mN
X
 i.e., all possible ways 
to choose mN   proteins from the remaining mnX   proteins which only interact with 
protein X; (iii)
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



mn
nN
Y
X   i.e., choose mnY   proteins that interact only with protein Y from 
the remaining XnN   available proteins. Then we calculated the total number of possible 
graphs, 
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N , in which protein X has Xn  neighbors and protein Y has Yn neighbors and 
the number of common neighbor is unfixed. By multiplying these three terms and then 
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dividing it by the total number of unrestricted ways for protein X to have Xn  and protein Y 
to have Yn interacting neighbors— 











YX n
N
n
N , we got the following formula (Algorithm I) 
developed by Samanta and Liang [75]: 
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We call this formula Algorithm I (P1) in this dissertation. Our simulations showed that, for 
the random PPI network as defined above, the probability P1 is accurate: the observed 
occurrence probabilities of m agreed with the probabilities (P1) calculated from Algorithm I 
(Fig.4). 
 However, since human PPI network is a scale-free network [23, 24,], hub proteins 
will be connected at a higher probability than proteins with only a few links, which is 
different from the random network proposed in [19]. Thus, it‘s more realistic to use a 
randomized scale-free PPI network as the control which keeps the same total number of 
edges and the same degree distribution as our human PPI network. For such a random 
scale-free network (we use ―random scale-free network‖ hereafter to refer to the randomized 
scale-free PPI network, unless otherwise specified), our simulations showed that P1 becomes 
inaccurate: it deviates more sharply from the observed occurrence probabilities of m as m 
becomes larger (Fig. 5). In addition, we found that, as common neighbors, hub proteins (i.e. 
high-connectivity proteins) will appear at an extremely high frequency (Fig. 6, 7), comparing 
with the frequency of their occurrence in a random network; it also becomes relatively rare to 
observe low-connectivity proteins in A (the set of common neighbors) comparing with their 
dominant status in the random network. Since observing a hub protein in A is much easier 
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than observing a non-hub protein in A, the significance of P1 needs to be down-weighted if 
there exists many hub proteins in A. An obvious example to justify this statement is that, if 
one protein interacts with most proteins in the network, it is not a surprise to find two proteins 
sharing it as a common neighbor. Therefore, since P1 cannot tell whether or not common 
neighbors are hub proteins, we developed another algorithm to measure the connectivity of 
common neighbors so that we can reduce the influence of hub proteins on our assessment of 
protein functional associations: we assume that any protein in D, except X and Y, randomly 
and independently connects other proteins with an equal probability which only depends on 
its own degree, and all possible (connecting) graphs in the network have the same probability 
to happen. Thus we were able to use the degree  of D  (excluding the degree of X and Y) 
to compute the probability that only },......,{ 21 mZZZ  connects to X and Y, and we 
arrived at the following formula: 
),|(2 NAshareYandXP   
),|(]),|([
1
NYandXbothconnectsproteinothernoPNYandXbothconnectsZP
m
i
i 


 
)
1
1
2
2
1
1
1(
1
1
2
2
1
1
,
































































iAi
i
i
i
i
Ai
i
i
i
i
n
N
n
N
n
N
n
N
n
N
n
N
n
N
n
N
 
)
)1(
)1(
1(
)1(
)1(
,

 





iAi
ii
Ai
ii
NN
nn
NN
nn
 
We call this formula Algorithm II. In Appendix A, we showed that the second product is 
bounded within a very narrow interval and can be considered as a constant, and we used the 
approximation 

P2 
ni(ni 1)
N(N 1)
iA
  for convenience in our dissertation. 
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 As shown above, each protein pair with at least one common neighbor can be 
assigned with both P1 and P2. In previous work on yeast PPI network, Samanta and Liang [75] 
only used P1 to rank the functional association of protein pairs. In our dissertation, we added 
P2 as a complementary algorithm to improve the quality of biological inferences. We later 
showed that, by reducing the influence of hub proteins in the network, the use of both P1 and 
P2 allowed us to identify a more reliable functional relationship than that identified by P1 
alone. [76]  
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Figure 4 Probabilities observed from random networks vs. probabilities calculated from 
Algorithm I. Green points (line) represent the observed probabilities for different m in 
random networks, and green dashed line represents the expected observation from the 
random networks (m=5 cannot be observed based on the times of our simulation). Red points 
(line) represent the theoretical probabilities calculated from algorithm I. We performed 
simulations 1000 times for a random network with 100 nodes and 300 interactions (n1 and n2 
are the degrees of protein X and Y, N is the size of the network). Fig. 4 is an example taken 
from our simulation. 
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Figure 5 Probabilities observed from random scale-free networks vs. probabilities 
calculated from Algorithm I. Green points (line) represent the observed probabilities for 
different m in random scale-free networks, and green dashed line represents the expected 
observation from random scale-free networks (m=5 cannot be observed based on the times of 
our simulation). Red points (line) represent the theoretical probabilities calculated from 
algorithm I. Here the random scale-free networks were simulated 30 times based on the 
mouse PPI network (906 nodes and 1054 interactions) for computational convenience (i.e., 
the random scale-free networks used here have the same total number of edges and degree 
distribution as the mouse PPI network) [77]. In Fig. 5, n1 and n2 are the degrees of protein X 
and Y, N is the size of the network in our simulation. 
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Figure 6 Hub proteins always appear as common neighbors. Green points (line) represent 
the observed probability of seeing proteins with the same degree in random scale-free 
network, and red points (line) represent the observed probability of seeing proteins with the 
same degree in the common neighbor set A in the random scale-free network. 
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Figure 7 Hub proteins are more inclined to appear as common neighbors. The black 
points stand for the ratios of each two corresponding observed probabilities from Fig. 6 
(red/green). Ratio becomes larger as degree increases, which means hub proteins are more 
inclined to appear as common neighbors. 
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Algorithm I and II Distinguishes the Human PPI Network from Random 
Networks and Random Scale-free Networks 
 We first applied the two algorithms on our human PPI data and computed the 
probabilities (P1 and P2) for 311,023 protein pairs that had at least one common neighbor. We 
then applied the two algorithms on the aforementioned random networks and random 
scale-free networks and calculated P1 and P2 for around 500,000 and 150,000 proteins pairs, 
respectively. To assess the statistical significance of the topological connections in the human 
PPI network, we first compared the number of common neighbors between the three types of 
networks, then we compared the distribution of probabilities calculated from them and 
plotted the distributions (Fig. 8). Comparing to the random network, the random scale-free 
network have a much more similar behavior as the human PPI network. Since biological 
networks, including PPI networks, are scale-free networks, it is more reasonable to use 
random scale-free networks as the benchmark for comparisons. As expected, the human PPI 
network has many highly improbable topological connections which would almost 
impossibly happen in random and random scale-free networks. [76] 
*In this dissertation, all probabilities (P1 and P2) have been natural logarithm (base e) 
transformed. 
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Figure 8 Density distributions and histograms of P1 and P2 derived from Algorithm I 
and II. In all four plots, red, green and blue stands for the results (density distribution and 
histogram) calculated from the human PPI network, the random scale-free network and the 
random network, respectively. (a) Density distributions of P1. (b) Density distributions of P2. 
(c) Histograms of P1. (d) Histograms of P2. Fig.8 was reproduced from REF. 76. 
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Algorithm I Identifies Functionally Associated Proteins in Human PPI 
Networks  
 P1 is able to assess the degree of nonrandomness and suggest protein functional 
associations in the yeast PPI network [75]. Since human and yeast PPI networks share plenty 
of common characteristics, we expected P1 to do the same thing in our human PPI network: 
ranking protein pairs in terms of their functional association. Therefore, we hypothesized that 
a higher ranking (the smallest P1 is ranked highest) corresponds to a closer functional 
relationship. With the Gene Ontology (GO) annotations [79] and Kyoto Encyclopedia of 
Genes and Genomes (KEGG) pathway annotations [80] as benchmarks, we used annotation 
overlap rate (see Methods and Materials) to test our hypothesis: if protein pairs of higher 
ranking have better annotation overlap rate, our hypothesis is validated; otherwise rejected. 
From Fig. 9 we can see that, overall, annotation overlap rate becomes higher as ranking goes 
higher, which validates our hypothesis. Here we also noted in Fig. 9 that, in the top 5,000 
protein pairs, each 1,000 pairs always had a higher overlap rate than those beyond the top 
5,000 pairs, and that the region of high overlap will give us a high level of confidence in 
presenting reliable predictions. Thus, we chose the 5,000
th
 value (–17.11) of P1 as the cutoff 
from Algorithm I, which also perfectly matches the Bonferroni correction )
)1(
2
ln(
NN
 in 
which N =7,362 is the size of the whole protein network. In order to further assess the 
performance of our method, we defined a false discovery rate (FDR) [81] (see methods and 
materials). For the top 5,000 protein pairs selected by Algorithm I, the FDR is 0.40. 
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Figure 9 Annotation overlap rate with GO and KEGG as the benchmarks. Protein pairs 
are ranked by P1. The top-ranked 20,000 pairs are divided equally into 20 bins. In each bin 
(1,000 protein pairs), we calculated the GO overlap rate and the KEGG overlap rate. The red 
curve stands for the GO overlap rates and the blue one stands for the KEGG overlap rates. 
The dashed line is the cutoff (–17.11) at the 5,000th protein pair. The correlation coefficient 
between the two groups of overlap rates is 0.928 (P<0.0001). Fig. 9 was reproduced from 
REF. 76. 
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Algorithm II Improves the Evaluation of Functional Associations 
 As mentioned in previous paragraphs, P2 is designed to reduce the influence of hub 
proteins which commonly exist in scale-free networks. Here we hypothesis that, within the 
top 5,000 protein pairs selected by P1, P2 can identify and remove protein pairs whose small 
P1 is mainly caused by hub proteins in their common neighbor set, hence identify better 
functional associations among proteins. After manually inspecting the top 5,000 protein pairs, 
we found a considerable amount of protein pairs whose good P1s are caused by hub protein, 
and we listed some as examples in Table 1. With GO and KEGG as the benchmarks, we 
validated our hypothesis on P2 by the following assertions: ―(i) the protein pairs with a good 
P2 (Group I) always have a lower FDR (here a lower FDR means a closer functional 
relationship) than those without a good P2 (Group II; Fig. 10a); and (ii) the protein pairs with 
a good P2 (Group I) always have a lower FDR than the same number of top protein pairs 
ranked by P1 only (Group III; Fig. 10b). We also noted that because P1 and P2 have a very 
low linear correlation (Pearson‘s correlation coefficient = -0.033, P<10-16; also see Fig. 11a) 
and rankings of functional association by P1 and P2 are significantly different (P<10
-16
), an 
additional cutoff from Algorithm II makes difference from simply tightening the cutoff from 
Algorithm I. As the cutoff for P2 changes, the difference in FDR between Groups I and II 
varies; the difference maximizes when the cutoff goes to –30.03, which is the value we used 
for the second cutoff from Algorithm II (Fig. 10a). ‖ ψ Therefore, 4,233 protein pairs (see 
Table S1 in Appendix B) were considered to have significant functional associations 
(P<0.001) in terms of the cutoffs from Algorithm I (–17.11) and Algorithm II (–30.03), and 
we call them significant protein pairs in this dissertation for convenience. Furthermore, FDR 
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of the 4,233 significant pairs is only 0.35, compared with 0.39 of the top 4,233 pairs ranked 
by P1 only (Fig. 10b). [76] 
ψ
 In this dissertation, all quoted paragraphs were cited from REF. 76. 
 Due to the incompleteness of functional annotations for human genes and proteins, 
the annotation (GO and KEGG) based FDRs (0.35) are probably overestimated. Although it 
was very hard to obtain ―true‖ FDR from annotations, we still estimated its lower bound by 
comparing the behavior of the human PPI network with the random scale-free networks: with 
the same cutoff (–17.11 for P1 and –30.03 for P2), we generated false significant protein pairs 
in random scale-free networks for multiple times; by dividing the averaged number (86) of 
false significant pairs by our predicted significant pairs (4,233), we determined the lower 
bound of FDR should be approximately 2% (Fig. 11). [76] 
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Figure 10 Algorithm II decreased the false discovery rate (FDR) of our predictions.  
―(a) For the top 5,000 protein pairs ranked by P1, each cutoff value from P2 (on the x axis is 
the quantile of P2 we used as the cutoffs) divided them into two groups: Group I (red line), 
whose P2 was better than the cutoff, and Group II (blue line), whose P2 was worse than the 
cutoff. In this plot, the maximal difference between the two groups is at 0.039 (vertical 
dashed line), which corresponds to the cutoff of –30.03 from Algorithm II. The horizontal 
dotted line stands for the FDR (0.40) of the top 5,000 protein pairs ranked by P1. (b) The blue 
line (Group III) shows the FDR of protein pairs ranked by P1 only (x axis stands for the 
amount of selected top protein pairs), and the red line (Group I) shows the FDR of the 
significant protein pairs selected by P1 and P2 together.‖
 ψ Fig. 10 was reproduced from REF. 
76. 
  
 - 27 - 
 
 
Figure 11 Smoothed color density representation of the scatter plot of P1 and P2. (a) The 
human PPI network. (b) The random scale-free network. The vertical and horizontal lines 
represent the cutoffs for P1 (–17.11) and P2 (–30.03), respectively. In a random scale-free 
network, the expected number of significant protein pairs is 86 (lower left area in b), 
compared with the number of 4,233 in our human PPI network (lower left area in a). Fig. 11 
was reproduced from REF. 76. 
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Significant Protein Pairs Are Highly Informative in Functional Inference 
 Within the top 4,233 significant protein pairs, we observed strong functional 
relationships: by manual inspection, we found that at least 96 of the top 100 protein pairs 
(unannotated proteins were excluded) are functionally associated (see Table 2 for the top 10 
protein pairs); with GO and KEGG as benchmarks, the FDR of the top 4,233 protein pairs is 
0.35, compared with 0.83 of the top 4,233 pairs from the random scale-free network [cutoffs
ж
: 
-8.90 for P1 and -11.33 for P2] and 0.92 of the top 4,233 pairs from the random network 
[cutoffs
ж
: -6.42 for P1 and -13.10 for P2]. [76] 
ж 
the cutoff for P1 is the value of the 5,000th protein pair's P1; the cutoff for P2 is the value of 
4,233th protein pair's P2 when the 5,000 protein pairs are ranked by P2. 
 Most of the direct interactions in our PPI data are from traditional experiments, and 
the rest are high-throughput data which were also strictly selected [23, 24, 77] (for details of 
our dataset, see methods and materials). With GO and KEGG as the benchmarks, FDR for the 
23,782 direct interactions is 0.57. This is significantly higher than the FDR of the top 4,233 
protein pairs (𝑃 < 10−16 by two-sample proportion test). From here we can conclude that, 
our method probably identifies more reliable functional associations than the original PPI 
data does. Furthermore, among our 4,233 significant protein pairs, only 21.6% share direct 
interaction, which makes we believe our method reveals a substantial amount of functional 
information that is not present in experimentally acquired PPI data. [76] 
―Among the 1,754 proteins in the top 4,233 protein pairs, 1,220 have qualified GO 
terms (i.e., GO terms at the highest level without direct or indirect GO ―offspring‖ terms in 
each ontology), and 834 have KEGG pathway annotations. If a protein has at least one 
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annotated significant partner (i.e., two proteins are significant partners to each other if they 
are a significant protein pair), a list of annotation(s) from its partner(s) can be sorted by 
frequency and annotations occurring at the highest frequency are assigned to this protein 
(frequency must be at least twice for KEGG and four times for GO; otherwise discarded.‖ ψ 
For more details, see Fig. 12 and Appendix A). ―For an annotated protein (based on GO and 
KEGG annotations), if an assigned annotation occurs among its known functions, we 
consider this to be a correct prediction. By this method, we found that 79% (for KEGG) and 
70% (for GO) of assigned annotations were correct predictions. (Randomly picking 4233 
pairs from 1729 proteins will only yield a 7% correct prediction rate for KEGG and 12% for 
GO on average from 100 trials.)  In the same way, we predicted 466 KEGG pathways for 
274 proteins and 123 GO terms for 114 proteins. We estimated that the FDRs of our 
predictions are much less than 21% (for KEGG) and 30% (for GO) because of the percentage 
of correct predictions for annotated proteins and the incompleteness of GO and KEGG 
annotations.‖ ψ In addition, for each prediction, we assigned a P value to further assess the 
significance of the assigned annotation(s) under Fisher‘s exact test (see methods and 
materials). For brevity, we only selected 40 predicted annotations and listed them in Table 3 
as an example (20 KEGG annotations and 20 GO annotations). For the list of complete 
predictions, please refer to Table S2 in Appendix B. [76].  
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Figure 12 Estimation of prediction precise rates and the number of predictions we can 
make given different n. ―(n is the minimal frequency of annotation occurrence required for 
functional prediction). (a) Estimated precise rate of predicted KEGG pathway given n. (b) 
The number of predictions for KEGG pathway we can make given n. (c) Estimated precise 
rate of predicted GO terms given n. (d) The number of predictions for GO terms we can make 
given n.‖ ψ Fig. 12 was reproduced from REF. 76. 
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External validation of predicted GO annotations 
 Our predictions of GO annotations were based on R package: GO, 08-Aug-2006. 
Among our 123 GO term predictions, 17 annotations have already been validated and 
approved by an independent GO annotation coordinator - Emily Dimmer (see Table 4 for 
details). These approved GO annotations will be probably put into GO SeqdbLite with an 
evidence code of ―IC‖, where IEA associations are removed and annotations are considered 
to have a relatively low error rate of 28%-30% [82]. 
 
 
  
 - 32 - 
 
Clustering Based on Significant Pairs can Effectively Identify Signaling 
Pathway Members 
 ―Because clustering can significantly improve the quality of functional inference [75], 
we built a cluster consisting of 1,729 proteins (excluding 25 non-human proteins) based on 
the P1 of 4,233 significant protein pairs. We constructed the empirical cumulative distribution 
from these P1 values; thus, each significant protein pair had a score between 0 and 1 
according to its ranking order in the distribution of P1. Then we built a 17291729   
dissimilarity matrix in which each matrix element was assigned either a score (if applicable) 
or a ―10‖ for pairs with no significant P1. The purpose of using such a large value was to 
minimize background noise. Then the dissimilarity matrix was subjected to agglomerative 
hierarchical clustering with an unweighted pair-group average. The whole cluster is given in 
Fig. S1 in Appendix C.‖ ψ [76] 
 We made detailed analysis on functional modules with significant P values. ―In the 
cluster of 1,729 proteins, most of the functionally related proteins were correctly clustered 
into their corresponding functional modules, in which they are characterized by similar 
functions or the same pathway (Fig. 13). The largest subcluster derives directly from the root 
of the whole cluster and consists of 959 proteins; the second-largest subcluster has only 51 
members (Appendix C).‖ ψ We used Ingenuity Pathway Analysis (IPA 5.0) to analyze the 
largest subcluster and found that a large number of signaling pathways were highly enriched 
there: 57 signaling pathways had extreme P values less than 10
-10
 after P value adjustment 
[81] (Fig. 14). ―We cut the 959-member subcluster with different cutoff values and analyzed 
the corresponding subclusters by using both manual inspection and Ingenuity Pathway 
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Analysis (IPA). We conducted a detailed analysis for one prominent subcluster (the subcluster 
related to the TGF-β signaling pathway) as a reference.‖ ψ [76] 
―The TGF-β signaling pathway–related subcluster (Fig. 15a) has a total of 45 protein 
members, 35 of which are known to participate in the TGF-β signaling pathway, according to 
the Ingenuity database. The probability of observing this by chance is < 10−54, according to 
the calculation from Ingenuity software (right-tailed Fisher‘s exact test). With respect to this 
extreme P value, we reasoned that probably all the cluster members cooperate to mediate 
signal transduction. To investigate the role of the other 10 proteins in the TGF-β signaling 
pathway, we generated a functional relationship network using Osprey software 
(http://biodata.mshri.on.ca/osprey) [83] to explicitly elucidate the relationships between the 
45 proteins (Fig. 15b): the 10 proteins not related to TGF-β according to the Ingenuity 
database are located inside a circle, whereas the other 35 TGF-β member proteins lie on the 
circle; common neighbors which do not belong to the 45-member subcluster stay outside the 
circle.‖ ψ [76] 
―The cluster and the association network (Fig. 15a and 15b) intuitively suggest 
possible roles that the inner proteins play in the TGF-β signaling pathway, which have not yet 
been incorporated into the Ingenuity pathway. Take Fig. 15b for instance: SKI functions as 
both the significant partner and the direct interacting neighbor of SMAD2 and SMAD3, and 
the three proteins‘ common neighbors (five violet nodes) all share the function of 
transcriptional regulation. From this we infer that SKI may regulate the TGF-β signaling 
pathway on a transcription level, which is in accordance with findings in the literature (but 
has not been incorporated into the Ingenuity database) that SKI regulates downstream DNA 
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transcription by forming a protein complex with SMAD2 and SMAD3 [84-85]. With respect 
to IGSF1‘s significant partners, direct-interaction partners, and the previous work identifying 
IGSF1 as a potential receptor that could affect cellular response through its cytoplasmic 
region [86], we suspect that IGSF1 could function as a coreceptor for inhibin and/or activin. 
SOSTDC1 and NOG may regulate TGF-β by interacting with BMP receptors, which is in 
accordance with the findings that both of them function as BMP antagonists [87, 88]. In 
addition to positive regulatory functions [89], DAB2 may serve as an antagonist of STRAP, 
which has a negative regulation on TGF-β–mediated transcriptional activation [90, 91]. 
FMOD, CTGF, and SLITL2 may be involved in regulating receptor binding of TGF-βs, in 
accordance with published findings [92-94], and they may interact with each other.‖ ψ [76] 
Therefore, based on our analysis of TGF-β signaling pathway–related subcluster, we 
suggested possible roles for eight proteins in TGF-β signaling pathway (Table 5). Some of the 
suggested functions have supporting literatures, while others (shown in bold in Table 5) have 
none. Those functions without any literature support are worth further experimental 
investigation by biologists. 
―To facilitate analysis of this type, we proposed eight signaling pathways that are 
worthy of further investigations (Fig. 16), under the assumption that proteins within the same 
signaling pathway tend to stay together in the same subcluster. This is shown for the largest 
959-member subcluster (Fig. 16a; cluster members are indexed from 1 to 959). From 
IPA-based classification of the proteins into each of the eight pathways, we calculated a 
density distribution for all eight signaling pathways along the cluster (Fig. 16b–e). Each 
pathway is expected to have a distinct distribution (its own peaks). The peaks in Fig. 16b–e 
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map to some areas (i.e., subclusters) that are probably highly related to their corresponding 
pathways.‖ ψ Functionally intercrossed pathways, like death-receptor/NF-B signaling, may 
probably have peaks close to each other. Moreover, we calculated the density distribution of 
the same eight signaling pathways in the largest cluster from random network and found no 
obvious peaks (Fig. 17). We believe these distribution patterns from real PPI networks are 
useful in identifying pathway-specific regions in the cluster. ―We selected another 4 
subclusters that are presumably involved in six signaling pathways (excluding TGF-β) with 
respect to pathway member distributions, and listed the potential pathway members in Fig. 18. 
We expect that the clusters and distributions will help biologists to find their subcluster of 
interest and discover new pathway members.‖ ψ [76] 
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Figure 13 7 subclusters derived from the 4,233 significant protein pairs. It is obvious that 
they all belong to their own functional module where members perform similar or related 
biological functions. Fig. 13 was reproduced from REF. 76. 
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Figure 14 57 highly enriched signaling pathways with P values less than 10
-10
 in the 
largest subcluster. The height of blue bars indicates unadjusted P value for each signaling 
pathway. The yellow dots mean the ratio of pathway members in the subcluster over all 
pathway members in IPA 5.0. 
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Figure 15 TGF-β signaling pathway–related subcluster. ―(a) One subcluster identified by 
our method consists of proteins presumably involved in the TGF-β signaling pathway. (b) 
Detailed interpretation of the relationships between each protein from the subcluster. On the 
basis of the Ingenuity Pathway Analysis 5.0, the 35 blue-green proteins on the circle 
participate in the TGF-β signaling pathway, and the 10 red proteins inside the circle are 
unrelated. The violet proteins outside the circle are common neighbors that do not belong to 
the subcluster in panel a. Red lines represent significant protein pairs, green lines represent 
direct protein–protein interactions, and yellow lines represent both.‖ ψ Fig. 15 was reproduced 
from REF. 76. 
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Figure 16 Distribution patterns of eight different signaling pathways. ―(a) The largest 
subcluster of 959 proteins is derived from the root of the whole 1729-member cluster. Each 
 - 42 - 
 
protein in this subcluster has a coordinate with respect to its order in the 959 members (from 
left to right); a pathway distribution is generated from the distribution of its members‘ 
coordinates under the bandwidth of 10 (R 2.25; IPA 5.5). (b) Distribution of the TGF-β 
signaling pathway. (c) Distributions of death-receptor and NF-B signaling pathways. (d) 
Distributions of B- and T-cell receptor signaling pathways. (e) Distributions of insulin 
receptor, Fc epsilon RI and natural killer cell signaling pathways.‖ ψ Fig. 16 was reproduced 
from REF. 76.  
 - 43 - 
 
 
Figure 17 Distribution patterns of eight signaling pathways (the same as those in Fig. 16) 
from the random scale-free network. This largest of 2425-protein subcluster was derived 
from the root of the whole 3033-protein cluster which came from random scale-free network. 
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Similar as Fig. 16, each protein here has a coordinate which was used to generate 
distributions of signaling pathways under the bandwidth of 10 (R 2.9.0; IPA 8.5). Here, (a), 
(b), (c) and (d) correspond to Fig. 16 b, c, d, e, respectively. (a), (b), (c) and (d) were 
generated in the same way as in Fig. 16.  
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Figure 18 Four subclusters that are presumably involved in six signaling pathways. The 
indices above protein names are their coordinates in Fig. 16a). (a) The subcluster for NF-B 
signaling pathway (𝑃 < 3.2 × 10−20): RIPK2, TRAF3IP2, TRAF1, TRPC4AP and TANK 
are potential pathway members. (b)The subcluster for death receptor signaling pathway 
(𝑃 < 2.4 × 10−19): DEDD, DEDD2 and CASP8AP2 are potential pathway members. (c) The 
subcluster for insulin receptor signaling pathway (𝑃 < 2.4 × 10−10): PTPN14, PKD1 and 
SOCS2 are potential pathway members. (d)The subcluster for the immune response [natural 
killer cell signaling (𝑃 < 1.7 × 10−21), T-cell receptor signaling (𝑃 < 4.9 × 10−22) and 
B-cell receptor signaling (𝑃 < 1.1 × 10−17)]: CRK, PTK2, PTK2B, SRC, PTPN12, PXN, 
CRKL, EVL, SIT1, KIT, IRS4 and NEDD9 are potential members of the above three 
pathways. Fig. 18 was reproduced from REF. 76. 
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Comparison of performance between our prediction scheme and others 
―We compared the performance of our prediction scheme with that of the direct 
prediction scheme used by Schwikowski et al. (2000) which infers the function of a protein 
from it direct interacting neighbors in the PPI network [95, 96].‖ ψ Under the same criteria 
[i.e., the same minimum number (n) of annotations (shared by direct interacting neighbors) 
required to predict a function], our prediction scheme gave better FDRs in most cases (expect 
n=7, 10 for KEGG predictions), while Schwikowski et al. (2000) gave more predictions at 
the cost of FDR (Fig. 19). From Fig. 12 and Fig. 19, we decided to use n=2 (for KEGG) and 
n=4 (for GO) as the thresholds of minimum number of annotations shared by significant 
partners, which gave us relatively low FDRs (21% for KEGG and 30% for GO) without 
sacrificing too many predictions (we obtained 466 predictions for KEGG and 123 predictions 
for GO were made). Under the same criteria (i.e., n=2 for KEGG and n=4 for GO), the FDRs 
of our predictions (30% for GO and 21% for KEGG) have been significantly improved over 
the FDRs (60% for GO and 49% for KEGG) from the direct prediction scheme [95], while 
the number of predictions we can make by our scheme has been dramatically decreased 
compared with that from Schwikowski et al. (2000) (Fig. 19). 
For GO annotations, when the numbers of predictions were similar, our prediction 
scheme always gave better FDRs than that from Schwikowski et al. (2000) (Fig. 20a). For 
KEGG pathways, when the number of predictions was greater or equal to 58 (dashed line in 
Fig. 20b), our prediction scheme still gave better FDRs. When the number of predictions goes 
below 58, direct annotation scheme may give better predictions in terms of FDR, but the 
number of predictions becomes very limited. These results are reasonable because our 
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algorithms identified significant protein pairs that are more functionally associated than the 
direct-interacting pairs in the human PPI data, and we made functional inferences from these 
significant pairs, not from direct protein interactions which may suffer large amounts of false 
positives generated in high throughput assays [76]. 
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Figure 19 Estimation of the false discovery rates and the number of predictions we can 
make given different n. The lines with solid dots came from our prediction scheme, which 
the lines with triangles came from the prediction scheme used by Schwikowski et al. (2000). 
(a) Estimated FDR of predicted KEGG pathway at a given n. (b) The number of predictions 
we can make at a given n for KEGG pathway. (c) Estimated FDR of predicted GO terms at a 
given n. (d) The number of predictions we can make at a given n for GO terms. 
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Figure 20 False discovery rates vs. the number of predictions. Solid dots stand for the 
FDRs of predicted annotations from our prediction scheme, triangles stand for the FDRs of 
predicted annotations from Schwikowski et al. (2000). (a) is for GO annotations and (b) is for 
KEGG annotations. Dashed line in (b) equals 58 (predictions). 
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 We compared our methods with the latest module-assisted method that used 
interactive hierarchical cluster to analyze functional modules of PPI data [97, 98]. Arnau et al 
(2005) used the shortest path length as the distance measure between proteins in PPI 
networks. When the ―ties in proximity‖ problem [99-101] was encountered, equally valid 
hierarchical clustering solutions were obtained randomly. Aldecoa et al (2010) improved the 
interactive clustering algorithm to make the implementation of algorithm faster; with their 
criteria, they were also able to determine the best partition for the dendrogram. After applying 
their algorithm (UVCluster as the interactive algorithm and UPGMA as tree algorithm, with 
8000 iterations) on our human PPI data, we got 900 functional modules (subclusters) 
consisting of 7,362 proteins. To compare the performance between their clustering method 
and ours, we calculated the ratio of proteins that have the most prevalent function (or 
pathway) within each functional module. By taking the sizes of different functional modules 
into account, we defined a weighted overlap rate (WOR) based on KEGG and GO 
annotations to compare the overall quality between their cluster and ours:  
 
 
Here gi and ki stands for the ratio of proteins that have the most prevalent KEGG and 
GO annotation in i
th
 functional module; ni stands for the size of i
th
 functional module; S 
stands for all functional modules in the cluster. Only those functional modules with at least 10 
members [i.e. ni >9 (usable subclusters)] will be used to calculate the WOR.  

weighted  KEGG  overlap  rate   
ki  ni
iS

ni
iS


weighted GO overlap rate   
gi  ni
iS

ni
iS

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Since the best partition of our cluster was not determined, we tentatively cut our 
cluster at different heights and calculated corresponding WOR. Then we compared the rates 
with that calculated from Arnau et al (2005) and Aldecoa et al (2010) (Fig. 21). Above the 
height of 8, the mean sizes of subclusters are comparable with that from Aldecoa et al (2010): 
for KEGG annotation, our method yields a maximized WOR of 0.394 at the height of 9.44, 
compared with the WOR of 0.243 from Aldecoa; at the height of 9.44, the mean size of 
usable subclusters is 17.67, compared with 16.78 from Aldecoa. For GO annotation, our 
method yields a maximized WOR of 0.418 at the height of 8.24, compared with the WOR of 
0.273 from Aldecoa; at the height of 8.24, the mean size of usable subclusters is 15.90, 
compared with 16.78 from Aldecoa. Since our clustering method didn‘t use any GO and 
KEGG annotation, the comparison at least shows that, with GO and KEGG annotation as the 
benchmarks, our clustering method can give better results than the best partition considered 
by Aldecoa. As for computing time, our method probably consumes much less time than 
Aldecoa if written in C/C++ since it doesn‘t require heavy computation at all.  
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Figure 21 Comparison between the performance of our clustering method and the other 
one (Arnau et al 2005; Aldecoa et al 2010). X-axis stands for the height where we cut our 
cluster (dendrogram). Y-axis stands for the weighted overlap rate for our clustering method. 
Red line stands for the weighted overlap rate calculated from the best partition derived from 
Arnau et al (2005) and Aldecoa et al (2010). 
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 ―An advantage of our prediction scheme, inherited from Samanta and Liang (2003), is 
the insensitivity to the high false positive rate of high-throughput PPI data. After adding 6086 
randomly generated interactions (30.4% of the real data, assuming at least 50% false positive 
rate for high-throughput data), we were still able to recover on average 93.4% of significant 
protein pairs; furthermore, >90% of falsely generated ―significant protein pairs‖ will become 
significant if we loosen the cutoffs of P1 and P2 a little to double the number of significant 
protein pairs. This will certainly offer more flexibility when selecting which PPI data to use.‖ 
ψ
 [76] 
―Human proteins may have multiple functions and belong to different functional 
modules, so different signaling pathways may also have some pathway members in common. 
It is thus reasonable to assume that the overlap of distribution (Fig. 16b–e), especially of 
peaks, may reveal the functional relevance of different pathways. For example, the 
death-receptor and NF-B signaling pathways overlap in the peak area, and the T- and B-cell 
receptor signaling pathways have a similar distribution. Therefore, the cluster and its pathway 
distributions will be useful in multi-pathway analysis and accurate function prediction.‖ ψ 
[76] 
With GO and KEGG as the benchmarks, we also compared the performance of P1 and P2 in 
terms of annotation overlap rate (Fig. 22): for the top 5,000 or top 10,000 protein pairs, where 
we can observe a smaller overlap rate when ranks go lower, P1 obviously has better 
performance. From 10,001
th
 protein pairs to 20,000
th
 protein pairs, it becomes hard to tell 
why one performs better. However, since significant protein pairs are always selected within 
the top 10,000 pairs where very close functional associations can be expected between 
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protein pairs [75, 76], we determined that P1 has a better performance than P2 on ranking 
functional association (Fig. 22). However, Algorithm II was not designed to beat Algorithm I 
by itself: Algorithm I calculates the probability that two proteins, A and B, share m common 
neighbors. The m common neighbors may contain proteins with any degree: proteins with a 
large number of connections (i.e. hub protein) or proteins with only a few connections. This 
difference Algorithm I cannot tell but Algorithm II can. P1 cannot tell because it does not take 
into account the degree of common neighbors. Algorithm II was designed so that a small P2 
indicates less connectivity of common neighbors, while large P2 indicates more connectivity. 
A very small P1 with a very small P2 means that, two proteins have an unusual large number 
of common neighbors which are not hub proteins, while a very small P1 with a large P2 
means that, two proteins have an unusual large number of common neighbors which are hub 
proteins (as shown in Table 1). Since Algorithm II was not designed to calculate the 
probability of sharing m common neighbors (i.e., not an improved algorithm based on 
Algorithm I), it‘s not a surprise to see P1 gives better ranking results if we directly compare 
P1 with P2. 
GO terms are widely adopted to enhance and/or verify the credibility of functional 
relationship: the overlap of GO terms indicates functional association [23, 24]. However, 
because of the highly complex hierarchy of the Gene Ontology tree, we may arrive at some 
false conclusions if we use GO terms at all levels indiscriminately. For example, the overlap 
of GO terms at a low level in the GO tree is always less meaningful compared with the 
overlap of its offspring GO terms. Therefore, in this dissertation, we used GO terms at the 
highest levels in the GO tree (see methods and materials) which were considered to be the 
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most detailed functional annotations we could obtain. 
The error rate of curated gene annotations can be significant (Jones et al 2007). The 
overall error rate of curated GO term annotations (excluding evidence code ―IEA‖) was 
found to lie between 28%-30%, which was better than the error rate (33% - 43%) of 
UniProt/SwissProt database annotations (the latter was widely considered to have a very high 
standard of curation) (Artamonova et al 2005; Jones 2007). The error rate of all GO term 
annotations (including ―IEA‖) is, as far as I know, unknown, but could be much higher than 
30%. (The error rate of KEGG pathway annotations is also unknown at this point). To test if 
our result is sensitive to the potentially high error rate of GO and KEGG annotations, we 
assessed the performance of our method after adding false annotations to 7,362 proteins. We 
first calculated the annotation distribution from all GO/KEGG annotations of 7,362 proteins; 
then we generated different amounts of GO/KEGG annotations from the distribution (10%, 
20% … 90%, 100% of all GO/KEGG annotations of the 7,362 proteins) and randomly 
assigned them to 7,362 proteins. We found that, although FDR will be higher for both blue 
and red curves (as shown in Fig. 23; please compare with Fig. 10), the result will still be the 
same: using P1 and P2 together will always be better than using P1 alone. 
―We also developed a new algorithm for computing the probabilities that three 
proteins share m interacting partners (see Appendix A). However, we found that if three 
proteins have a very low probability of sharing m interacting partners, in most cases two of 
them will have a very low P1. Because this algorithm is highly dependent on Algorithm I (P1), 
we do not think it provides more information worthy of further investigation. ‖ ψ [76] 
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Figure 22 Comparison between the performance of P1 and P2 in terms of annotation 
overlap rate. Protein pairs were ranked by P1 for the red curve and ranked by P2 for the blue 
curve. The top-ranked 20,000 pairs are divided equally into 20 bins. In each bin (1,000 
protein pairs), we calculated the GO overlap rate in (a) and the KEGG overlap rate in (b). (a) 
The red curve stands for the GO overlap rates of proteins pairs ranked by P1; the blue one 
stands for the GO overlap rates of protein pairs ranked by P2. (b) The red curve stands for the 
KEGG overlap rates of proteins pairs ranked by P1; the blue one stands for the KEGG 
overlap rates of protein pairs ranked by P2.  
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Figure 23 Algorithm II decreased the false discovery rate (FDR) of our predictions even 
after adding false annotations. The meaning of X-axis, Y-axis, dashed lines and solid 
colored (red and blue) curves are the same thing as shown in figure 10. These results were 
generated after we added 10%, 20% … 100% (indicated at the lower right corner in each plot) 
randomly generated annotations to the GO and KEGG annotations of all proteins used in this 
thesis. 
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Protein–Protein Interaction Data  
 ―From the BioGRID (www.thebiogrid.org), we downloaded the human PPI data 
(version 2.20), which derived from both conventional focused studies (~69.6%) and 
high-throughput studies (yeast two-hybrid and affinity capture; ~30.4%) [77]. There are 
20,019 total non-redundant interactions (excluding self-interactions) and 7,362 protein entries 
in this dataset, including 42 nonhuman proteins that interact with human proteins.‖ ψ [76] 
 
Benchmarks for Evaluating the Functional Association 
 ―We used GO and KEGG as independent benchmarks to assess the functional 
association of each protein pair. GO and KEGG databases provide specific pathways, 
functions and cellular components for proteins in our PPI data: we classified the 7,362 
proteins into 237 KEGG pathways and 1956 qualified GO terms (including biological process, 
molecular function and cellular component). These databases are good references for 
evaluating functional association because of its reasonable coverage of the genome and its 
large number of categories, which makes it improbable to have random matching of 
pathways. ‖ ψ [76] 
 
Annotation Overlap Rate 
 ―With GO annotation (R package: GO, 08-Aug-2006), we defined the GO overlap 
rate as follows: 
A
Q
T
T
rateoverlap  , where QT  is the number of protein pairs of which both 
proteins share at least one qualified GO term; AT  is the number of protein pairs of which 
both proteins are annotated with qualified GO terms. Here ―qualified GO terms‖ means GO 
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terms at the highest level without direct or indirect GO ―offspring‖ terms in each ontology 
(the level is defined as the number of nestings from the root node (level 1) in the Gene 
Ontology DAG file [79]).‖ ψ [76] 
 ―We defined the KEGG overlap rate in the same way as above (R package: KEGG, 
Release 41.1). We used the GO and KEGG overlap rates to assess the functional association 
of protein pairs: a higher overlap rate corresponds to a closer functional relationship.‖ψ [76] 
 
Definition of FDR for the Declared Significant Functional Associations 
 “Suppose the GO and KEGG pathways are complete: if both proteins in each pair 
have KEGG pathway identifiers and qualified GO terms, we call them declared positive 
protein pairs. If they share at least one identifier (either GO or KEGG identifier), we consider 
this declared association true positive; otherwise we consider it false positive. Therefore, the 
FDR can be written as follows: 
pairsproteinpos itivedeclaredofnumber
pairsproteinpos itivetrueofmbernu
FDR 1  .‖ ψ 
[76] 
 ―This false discovery rate is used to assess the performance of our algorithm as we 
expect an improved annotation scheme will lower the proportion of wrong predictions among 
declared significant functional associations. ‖ ψ [76] 
 
Fisher’s Exact Test 
 For each protein with an assigned annotation, we first calculated the number of its 
total neighbors and the number of neighbors with the assigned annotation; we then obtained 
the total number of proteins and the number of proteins with the assigned annotation from 
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corresponding databases (data were downloaded from NCBI and KEGG ftp on Aug 16
th
, 
2009 and Aug 21
st
, 2009, respectively). With these data, we performed Fisher‘s exact test 
(two sided) for each assigned annotation and adjusted P values by ―BH‖ method [81]. We 
listed the results in Table S2. 
 
Pathway Analysis Tool  
 In this dissertation, pathway members were identified by Ingenuity Pathway Analysis 
(IPA 5.0, 5.5 and 8.5; Ingenuity
®
 Systems, Inc., Redwood City, CA, www.ingenuity.com). P 
values for signaling pathways were calculated from Ingenuity Pathway Analysis. Fig. 14, 15, 
16 and 18 were generated through the use of Ingenuity Pathway Analysis. 
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SUMMARY AND FUTURE PERSPECTIVE 
Protein-protein interaction (PPI) network is a very useful tool to perform a large-scale 
protein function investigation in the post-genomic era. With high-throughput screening 
technologies such as yeast two-hybrid assays, biologists have immensely accelerated the 
accumulation of protein interaction data across human and model species. These newly 
available data have made it possible to build global PPI networks and hence study protein 
function in the context of a large-scale network.  
So far, partial protein interaction maps of model species have been depicted and 
network-based annotation schemes are being developed to investigate protein functions. Here 
we propose a new method to detect certain non-randomness in the protein-protein interaction 
network. Unlike analyses that measure non-randomness globally, such as on power-law 
distributions, our method measures and ranks non-randomness for each pair of proteins, 
which allows us to make large-scale functional predictions (>500) with high reliability. Our 
method also clusters proteins properly into functional modules that cover a variety of 
signaling pathways. Further analysis of modules with significant P values reveals the possible 
roles of proteins from the pathway perspective and highlights potential new members in 
certain signaling pathways important in cancer research.  
The method we proposed in this dissertation can be used as a general tool for high 
throughput functional annotations; it can also derive functional modules enriched in 
important pathways and identify potential new members, which will spur the additional 
interests from biologists. Besides PPI networks, our method is also applicable in other types 
of networks with a similar distribution of degrees (i.e. scale-free distribution), such as gene 
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regulatory network and human social network [9, 12].  
 Future studies focusing on common-neighbor based statistics should first address one 
important problem: how to combine Algorithm I and II into one single algorithm which takes 
into account the degrees of all proteins in PPI networks. Since using two algorithms together 
needs our arbitrary threshold(s), it becomes hard to run automatic computer programs to 
identify significant functional associations between proteins. By contrast, a single algorithm 
with a pre-set P value as the cut-off will not only make computer programming much easier 
and straightforward, but also help biologists better understand and utilize common-neighbor 
statistics in their research fields. 
 Another interesting perspective is the future application of our method with nodes (e.g. 
genes, proteins, annotations) from two totally different networks. For example, to assess the 
relationship between direct interacting neighbors in a PPI network, biologists probably want 
to check if any two interacting proteins share the same functional annotations which come 
from a totally different type of networks [23, 24] (e.g. GO annotations which are 
hierarchically ordered, and the KEGG pathway network). However, even the overlap of 
functional annotations does occur between two proteins, this doesn‘t mean any statistical 
significant without further analysis: two proteins may only share one common function which 
is ―ubiquitous‖ for proteins, such as ATP binding, Zinc ion binding and Calcium ion binding. 
We think our method, which can take into account both the number and the prevalence of the 
shared annotations, will probably be able to give a reliable statistical significance on the 
functional association between two proteins and reduce the influence of those ―ubiquitous‖ 
functions on future predictions. For the same reason, we may also be able to put P values on 
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our claimed ―true positive protein pairs‖ (see methods and materials) and possibly reduce 
false positive rates caused simply by random chance. Therefore, we believe our work in this 
dissertation is a very important and solid groundwork for future research.   
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CONCLUSION 
High throughput gene discovery by sequencing demands corresponding high 
throughput annotations. The protein-protein interaction data from high throughput assays has 
made it possible to study protein functions in the context of a large-scale network. However, 
the interactions acquired from high throughput assays suffer a high error rate. How to extract 
reliable functional inference from the error-prone network becomes more significant. We 
have developed a new method to detect certain non-randomness in the protein-protein 
interaction network. Unlike analyses that measure non-randomness globally, such as on 
power-law distributions, our method measures and ranks non-randomness for each pair of 
proteins. This allows us to make large-scale functional predictions with top-ranking protein 
pairs. We applied our method to human data and assigned >500 annotations for human 
proteins. In addition, we have built a cluster to better illustrate the functional association 
between proteins and highlight potential new pathway members in certain signaling pathways 
important in cancer research. 
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Table 1 Examples of protein pairs with a very good P1 that is caused by hub proteins. P2 
can identify these protein pairs and remove them from the top 5000 protein pairs.  
 
Protein A Protein B Common neighbors Degree of common neighbors 
Tssk3 Itk SMAD4, TGFBR1 108, 138 
FBXW5 ZNF439 KRTAP4-12, MDFI 73, 97 
CD33 PILRA PTPN6, PTPN11 58, 69 
SLC25A6 MCSP PLSCR1, KRTAP4-12 68, 73 
SHREW1 CA9 CTNNB1, CDH1 81, 28 
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Table 2 Top 10 protein pairs from our 4,233 significant protein pairs. All of them share 
close functional relationships. Table 2 was reproduced from REF. 76. 
 
Protein_A Protein_B Ln(P1) Functional Relationship 
SMAD3  SMAD2 –157.6068 SMAD family member 
TUBB TUBB2 –136.0437 Cellular structural activity 
PTPN11 PTPN6  –125.8552 Proliferation of cells 
BMPR1B TGFBR1 –124.9466 Differentiation of cells 
CALM2 CALM3 –124.9368 Calcium-modulated proteins 
MAPK1 MAPK3 –113.0905 MAP kinase family member 
CALM1 CALM3 –112.6375 Calcium-modulated proteins 
IXL MED9 –107.7585 Mediator complex 
PIK3R1 GRB2 –107.7070 Tyrosine phosphorylation 
CALM1 CALM2 –106.1716 Calcium-modulated proteins 
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Table 3 Selected Predictions of KEGG and GO annotations for human proteins. The 2
nd
 
column is the predicted KEGG and GO IDs for proteins in the 1
st
 column. The 3
th
 column is 
the corresponding KEGG pathway name and GO term. Ratio is the number of significant 
partners with the assigned annotation(s) divided by the total number of significant partners. P 
values were first calculated by Fisher‘s exact test and then adjusted by ―BH‖ method [81]. 
Table 3 was partially reproduced from REF. 76. 
 
Protein KEGG KEGG Pathway Name Ratio  P value 
CDC5L hsa04110 Cell cycle 4/5 1.09E-05 
DEDD hsa04210 Apoptosis 4/5 4.22E-06 
KSR2 hsa04010 MAPK signaling pathway 4/5 0.000171 
GMFB hsa04010 MAPK signaling pathway 6/6 3.44E-07 
ITGB1 hsa04640 Hematopoietic cell lineage 4/6 1.07E-05 
PTK2B hsa04630 Jak-STAT signaling pathway 21/68 1.39E-12 
GDF9 hsa04350 TGF-beta signaling pathway 5/5 3.91E-08 
ZIC1 hsa04340 Hedgehog signaling pathway 3/3 1.09E-05 
GRAP2 hsa04664 Fc epsilon RI signaling pathway 5/7 2.97E-07 
ACTR2 hsa04810 Regulation of actin cytoskeleton 5/6 6.83E-06 
PLCG2 hsa04660 T cell receptor signaling pathway 6/8 5.76E-08 
CD2 hsa04660 T cell receptor signaling pathway 5/6 3.46E-07 
TRPV4 hsa04670 Leukocyte transendothelial migration 3/10 0.00253 
USP7 hsa04060 Cytokine-cytokine receptor interaction 11/15 9.44E-10 
CCBP2 hsa04060 Cytokine-cytokine receptor interaction 4/6 0.000432 
SLA hsa04650 Natural killer cell mediated cytotoxicity 4/5 1.98E-05 
CSK hsa04650 Natural killer cell mediated cytotoxicity 10/15 1.32E-10 
RGS16 hsa04080 Neuroactive ligand-receptor interaction 5/14 0.00191 
STX1A hsa04130 SNARE interactions in vesicular transport 5/6 6.01E-09 
NAPA hsa04130 SNARE interactions in vesicular transport 4/6 
 
6.16E-07 
Protein GO ID GO Term Ratio P value 
KHDRBS1 GO:0005524 ATP binding 5/18 0.0151 
GNAI1 GO:0003924 GTPase activity 4/4 9.45E-08 
COL1A2 GO:0005587 collagen type IV 6/9 1.16E-16 
MCM10 GO:0008270 zinc ion binding 10/26 0.00206 
FN1 GO:0005509 calcium ion binding 6/18 0.000478 
SAA1 GO:0005509 calcium ion binding 4/11 0.00307 
ATP2B4 GO:0030955 potassium ion binding 4/16 1.52E-05 
ACTR2 GO:0005885 Arp2/3 protein complex 6/6 5.13E-18 
BLNK GO:0005070 SH3/SH2 adaptor activity 4/15 4.29E-07 
CD28 GO:0005070 SH3/SH2 adaptor activity 4/12 1.72E-07 
DLG4 GO:0004385 guanylate kinase activity 4/11 1.13E-09 
TIF1 GO:0003714 transcription corepressor activity 4/12 5.50E-06 
GADD45G GO:0030521 androgen receptor signaling pathway 4/8 1.22E-08 
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TNFRSF17 GO:0005031 tumor necrosis factor receptor activity 4/11 7.33E-10 
TNFRSF8 GO:0005031 tumor necrosis factor receptor activity 4/14 1.38E-09 
SOCS3 GO:0005159 insulin-like growth factor receptor binding 4/10 1.17E-09 
PTPN1 GO:0005159 insulin-like growth factor receptor binding 4/14 4.29E-09 
FAS GO:0043123 positive regulation of I-kappaB 
kinase/NF-kappaB cascade 
5/6 6.74E-10 
CASP10 GO:0043123 positive regulation of I-kappaB 
kinase/NF-kappaB cascade 
4/6 8.47E-08 
MAP3K14 GO:0043123 positive regulation of I-kappaB 
kinase/NF-kappaB cascade 
7/17 8.18E-11 
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Table 4 GO annotations that have been approved by GO annotation coordinator. The 
supporting literatures are listed in the 5
th
 column. 
 
Protein  GO ID  GO Term  Ontolog
y 
Supporting Literature Ratio  P value  
TRAF1  GO:0043123  positive regulation of I-kappaB 
kinase/NF-kappaB cascade  
P Yes. Literature support: PMID: 
9774460. 
4/10  7.74e-07  
BLNK  GO:0005070  SH3/SH2 adaptor activity  F Yes. This annotaton is supported by 
experimental evidence from: 
PMID:9697839  
4/15  4.29E-07  
GAB2  GO:0005070
;  
SH3/SH2 adaptor activity  F Yes. Supported by evidence from 
PMID: 10068651  
6/34  5.44e-09  
CD28  GO:0005070  SH3/SH2 adaptor activity  F Yes. Supported by evidence from 
PMID: 18295596  
4/12  1.72E-07  
GNAI1  GO:0003924  GTPase activity  F Yes. Supported by evidence from 
PMID: 2834384  
4/4  9.45E-08  
CASP10  GO:0043123  positive regulation of I-kappaB 
kinase/NF-kappaB cascade  
P Yes. Supported by literature: PMID: 
17822854  
4/6  8.47E-08  
IL4R  GO:0043560  insulin receptor substrate 
binding  
F Yes. Supported by PMID: 8124718  4/12  9.39e-10  
MAP3K14  GO:0043123  positive regulation of I-kappaB 
kinase/NF-kappaB cascade  
P Yes. Supported by PMID: 9020361  7/17  8.18E-11  
SIN3A  GO:0003714
;  
transcription corepressor 
activity;  
F Yes. Supported by PMID:11259580  4/16  1.57e-05  
NCOA2  GO:0030521  androgen receptor signaling 
pathway  
P Yes. Supported by PMID:17079484  5/12  7.33e-10  
NR0B2  GO:0030521
;  
androgen receptor signaling 
pathway;  
   
P Yes. Supported by PMID: 11705994  4/10  3.44e-08  
NR0B2  GO:0050681  androgen receptor binding F Yes. Supported by PMID: 11705994  4/10  1.02e-08  
TNFRSF19  GO:0043123  positive regulation of I-kappaB 
kinase/NF-kappaB cascade  
P Yes. Supported by PMID:18202551  4/19  1.00E-05  
ACTR2  GO:0005885  Arp2/3 protein complex  C Yes. Supported by PMID:9000076  6/6  5.13E-18  
TNFRSF17  GO:0005031  tumor necrosis factor receptor 
activity  
F Yes. Supported by PMID:10903733  4/11  7.33E-10  
TNFRSF8  GO:0005031  tumor necrosis factor receptor 
activity  
F Yes. Supported by PMID:9168896  4/14  1.38E-09  
TNFRSF11
A  
GO:0043123  positive regulation of I-kappaB 
kinase/NF-kappaB cascade  
P Yes. Supported by PMID:9774460  4/17  6.39e-06  
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Table 5 Suggested functions for proteins in TGF-β signaling pathway. Functions shown in 
bold characters don‘t have any supporting literatures (as far as we know).  
 
Protein  Possible roles in TGF-β signaling pathway  
SKI  Transcriptional regulation  [84-86] 
IGSF1  Coreceptor for inhibin and/or activin 
DAB2 Antagonist of STRAP 
SOSTDC1, NOG Interact with BMP receptors [87] 
FMOD, CTCF, 
SLITL2 
Regulating receptor binding of TGF-β proteins [92-94]; interact with each other 
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Formula derivation of Algorithm II 
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 For our human PPI network, N = 7,362, 451 m , 1571  in . Simulations 1,000 
times of the random PPI network and the random scale-free PPI network also showed the 
same results for N, m and ni. Thus, we are able to get the following inequality: 
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21 MM   and )log()log( 21 MM   
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  in our dissertation. [76] 
 
Mathematical expression for the probability that three proteins share m interacting 
partners 
―To compute this probability, we count the number of distinct ways in which three 
proteins with 1n , 3n  and 3n  interacting partners have m in common. We divide the whole set 
of partners of the three proteins into seven nonoverlapping groups: (i) m common protein 
partners that interact with proteins 1, 2 and 3; (ii) mn 12  proteins that interact only with 
proteins 1 and 2; (iii) mn 23  proteins that interact only with proteins 2 and 3; (iv) mn 13  
proteins that interact only with proteins 1 and 3; (v) mnnn  13121  partners that interact 
only with protein 1; (vi) mnnn  23122  partners that interact only with protein 2; and (vii) 
mnnn  23133  partners that interact only with protein 3. We count the total number of 
distinct ways of assigning these seven groups to N proteins. This is given by: 
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The total number of ways to randomly pick 1n , 2n  and 3n  proteins from N proteins is given 
by: 
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  ―Therefore, the probability that three proteins share m interacting partners is given as 
follows: 
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Assessing the reliability of functional predictions for GO and KEGG annotations 
―If a protein has at least one annotated significant partner, a list of annotation(s) from 
its partner(s) can be sorted by frequency. Suppose that annotations occurring n times or more 
will be assigned to this protein. For an annotated protein (based on GO and KEGG 
annotations), if an assigned annotation occurs among its known functions, we consider this a 
correct prediction. Assuming that GO and KEGG annotations are complete for those 
annotated proteins, we define a prediction precise rate as 
spredictionofnumbertotal
spredictioncorrectofnumbertotal
, and as n varies, we have different precise rates (Fig. 12) 
which we used to estimate the FDRs of our functional predictions ( ratepreciseFDR 1 ), 
hence to assess the reliability of our functional predictions. From Fig. 12, we decided to use 
n=2 (for KEGG) and n=4 (for GO) as the thresholds of minimum frequency of functions 
shared by significant partners, which gave us relatively low FDRs (21% for KEGG and 30% 
for GO) without sacrificing too many predictions (we made 466 predictions for KEGG and 
123 predictions for GO).‖ ψ [76] 
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Appendix B 
Table S1 The 4,233 significant protein pairs derived by our method (only top 1000 pairs 
are listed here for brevity). There are totally 1,729 human proteins and 25 nonhuman proteins. 
Protein pairs are ranked in terms of P1. Table S1 was partially reproduced from REF. 76. 
 
 
Protein A Protein B Ln(P1) Ln(P2) 
# of Common 
Neighbors 
1 SMAD3 SMAD2 -157.6068404 -597.2243748 45 
2 TUBB TUBB2 -136.0437454 -289.8610141 21 
3 PTPN11 PTPN6 -125.8551562 -424.3147331 33 
4 BMPR1B TGFBR1 -124.9465733 -599.6449534 38 
5 CALM2 CALM3 -124.9367504 -291.8124921 21 
6 MAPK1 MAPK3 -113.0905345 -384.8694846 27 
7 CALM1 CALM3 -112.6375413 -302.5388215 22 
8 IXL MED9 -107.7585446 -279.4824444 18 
9 PIK3R1 GRB2 -107.7069756 -489.2596327 42 
10 CALM1 CALM2 -106.1716277 -306.6247978 22 
11 RAC1 CDC42 -102.793931 -373.9517939 27 
12 FYN LCK -102.6697375 -358.873044 30 
13 HDAC1 HDAC2 -102.2579826 -358.5313968 28 
14 CREBBP EP300 -102.0552572 -420.1182758 32 
15 GRB2 SHC1 -99.65932503 -469.6442329 39 
16 SMAD2 SMAD4 -99.09164657 -460.3519272 34 
17 DLG4 DLG1 -96.76638457 -356.084827 26 
18 TRAF2 TRAF1 -95.58565584 -338.2088375 25 
19 BCL2L1 BCL2 -94.54649001 -324.8992611 23 
20 ACVR1 TGFBR1 -89.65577292 -467.2366865 30 
21 CPNE1 CPNE4 -87.91061912 -181.4118777 13 
22 MDFI KRTAP4-12 -87.88978999 -438.6963486 30 
23 SMAD3 SMAD4 -85.77343234 -435.3492838 33 
24 ACVR1 BMPR1B -84.52904218 -343.6074392 23 
25 COL4A3 COL4A2 -82.20398173 -167.9671211 13 
26 PTPN11 GRB2 -81.63255068 -383.1932153 32 
27 COL4A2 COL4A4 -80.7276668 -157.9221044 12 
28 PTK2 PTK2B -80.57310834 -240.1404574 22 
29 SRC FYN -79.46202476 -355.9045821 30 
30 COL4A3 COL4A4 -79.33974045 -157.9221044 12 
31 FYN LYN -79.00597291 -320.8620938 26 
32 RELA NFKB1 -78.83597444 -279.429444 23 
33 TRAF3 TRAF1 -78.157227 -213.0497868 16 
34 CSNK2A1 CSNK2A2 -77.73600946 -181.4968663 15 
35 JAK1 JAK2 -77.22522398 -233.6962148 20 
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36 PTPN11 PIK3R1 -74.97662001 -296.7887929 26 
37 COL4A2 COL4A1 -74.60859428 -151.9508426 12 
38 YWHAZ YWHAE -74.52029133 -245.9556029 19 
39 JUN FOS -74.00815036 -250.4496582 21 
40 RBL2 RBL1 -74.0078444 -175.0053511 14 
41 COL4A5 COL4A6 -73.93034147 -123.3558506 10 
42 NR3C1 AR -73.72738905 -289.2367706 25 
43 NR3C1 ESR1 -73.72738905 -292.7791161 25 
44 SUMO1 UBE2I -73.5062065 -258.2503183 20 
45 COL4A3 COL4A1 -73.22107635 -151.9508426 12 
46 DLG4 DLG3 -73.17886306 -232.2327749 17 
47 HDAC1 SIN3A -72.47932222 -266.6637009 21 
48 IRS2 IRS1 -71.88001114 -151.8096496 14 
49 COL4A1 COL4A4 -70.72591947 -141.9058259 11 
50 IKBKB CHUK -69.96305423 -162.9136822 14 
51 GADD45B GADD45G -69.56739182 -130.2946982 11 
52 GRB2 PLCG1 -69.39340099 -337.6520463 28 
53 JUP CTNNB1 -69.25868254 -254.9584259 19 
54 PLSCR1 KRTAP4-12 -68.91001314 -329.6901377 23 
55 PTPN11 SHC1 -68.90609068 -272.90666 24 
56 PIK3R1 SHC1 -68.82244231 -294.9077988 26 
57 ESR1 ESR2 -68.16817601 -221.2853544 17 
58 DLG2 DLG3 -67.29158995 -151.719371 12 
59 TBP GTF2B -66.86509738 -191.3382891 16 
60 COL4A2 COL4A5 -65.9161763 -123.3558506 10 
61 COL4A2 COL4A6 -65.9161763 -123.3558506 10 
62 COL4A1 COL4A5 -65.9161763 -123.3558506 10 
63 COL4A1 COL4A6 -65.9161763 -123.3558506 10 
64 SRC GRB2 -65.68304701 -369.6892177 31 
65 AR ESR1 -65.36120402 -294.273143 24 
66 COL4A3 COL4A5 -64.93398687 -123.3558506 10 
67 COL4A3 COL4A6 -64.93398687 -123.3558506 10 
68 RARA RXRA -64.11053408 -215.3482183 17 
69 TRAF3 TRAF2 -64.01676383 -260.0936955 19 
70 DLG4 DLG2 -63.98188409 -202.8927639 15 
71 COL1A1 COL1A2 -63.24777014 -151.5867474 12 
72 TGFBR1 SMURF1 -62.87519103 -423.9212755 27 
73 ORC2L MCM3 -62.62470809 -143.1193491 11 
74 GRB2 FYN -62.50403476 -353.978848 30 
75 FLJ22494 LNX -61.76207239 -191.962379 15 
76 TNFSF13 TWE-PRIL -60.6242878 -105.0219606 8 
77 PSEN1 PSEN2 -59.82978047 -172.4340654 12 
78 SHANK2 SHANK1 -59.63303509 -125.6225476 9 
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79 COL4A4 COL4A5 -59.6305881 -113.3108339 9 
80 COL4A4 COL4A6 -59.6305881 -113.3108339 9 
81 GRB2 CRKL -59.62441316 -240.3660842 21 
82 NIF3L1 LNX -59.17599865 -179.0708543 15 
83 KRT15 DIPA -59.0531779 -283.1457656 22 
84 HDAC4 HDAC5 -58.97406646 -131.1471165 11 
85 NCOR1 NCOR2 -58.96941997 -160.9803545 14 
86 GRB2 EGFR -58.92264739 -339.0230987 29 
87 DDIT3 CEBPG -57.53762273 -144.3332532 11 
88 NCOA1 NCOA2 -57.49927497 -148.7111631 13 
89 TGFB1 TGFB2 -57.37723082 -148.0591844 11 
90 TRAF2 TRAF5 -57.35284724 -187.591848 14 
91 PIK3R1 PLCG1 -57.07816398 -234.8728064 21 
92 PTPN6 VAV1 -56.80604805 -182.1499538 17 
93 PTK2 PXN -56.6283112 -199.3110295 17 
94 YWHAE YWHAB -56.36045703 -168.5263529 14 
95 NCOA1 PPARBP -56.35164632 -147.0223305 13 
96 TCEB2 TCEB1 -56.22888739 -116.397614 8 
97 RAC1 RHOA -55.93112463 -243.8942209 17 
98 STX1A STX4A -55.66368681 -170.1849433 12 
99 IGF2 IGF1 -55.36089149 -129.1709752 9 
100 PAG1 CBL -55.22086551 -119.852138 12 
101 YWHAZ YWHAB -54.86337875 -193.8031874 15 
102 SMN2 DDX20 -54.80372312 -123.8406098 9 
103 GNAI2 GNAI3 -54.55428285 -171.4575127 12 
104 MCM7 MCM2 -54.4577214 -155.7905121 12 
105 ESR1 RXRA -54.42433382 -233.5142756 19 
106 SYK VAV1 -54.32372654 -168.6185713 15 
107 SRC PIK3R1 -54.26967037 -271.9053986 23 
108 GNAI1 GNAO1 -54.13038371 -171.8454402 12 
109 RBBP4 HDAC1 -53.99133316 -149.8446323 13 
110 RIBC2 TU3A -53.78938962 -105.218086 10 
111 JAK2 PTPN11 -53.6548795 -198.1082041 18 
112 JUN JUND -53.56563793 -156.5032226 13 
113 ERBB2 EGFR -53.37266001 -194.4930757 17 
114 IL8RB IL8RA -53.31826358 -125.3057676 8 
115 SMN2 GEMIN5 -53.31826358 -107.4878591 8 
116 DIPA KIAA0980 -53.21491811 -248.0511319 18 
117 GRB2 LCK -53.08345707 -258.9204744 22 
118 K-ALPHA-1 TUBA2 -53.0093322 -94.17201147 8 
119 PTPN6 SHC1 -52.93501896 -209.5488701 19 
120 CPNE2 CPNE1 -52.61692073 -105.5499929 8 
121 CPNE2 CPNE4 -52.61692073 -105.5499929 8 
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122 INSR IGF1R -52.60883246 -152.7198638 13 
123 CCR5 CCBP2 -52.53526685 -146.9777368 10 
124 CDC27 CDC16 -52.21869964 -96.02430266 8 
125 EGFR INSR -52.00018901 -199.9203353 17 
126 NCOA1 RELA -51.4879004 -181.7950369 17 
127 TGFB3 TGFB2 -51.2665869 -107.9942436 8 
128 ERBB2 ERBB3 -51.14620615 -124.7513678 11 
129 KIAA0408 RIBC2 -51.11713523 -107.8027107 10 
130 PLCG1 SHC1 -51.09921926 -217.1652406 19 
131 NCOR1 SIN3A -51.06007248 -162.6756772 13 
132 TRAF3 TRAF5 -51.05966346 -135.8949254 10 
133 PSMA2 PLK1 -50.92646954 -157.7437897 10 
134 SYK ZAP70 -50.85333953 -147.3483587 13 
135 NCOA1 NCOA3 -50.47714922 -134.0379987 12 
136 JUND JUNB -50.379487 -106.6247075 9 
137 LRP2 LRP1 -50.17507279 -184.9652614 14 
138 TGFB1 TGFB3 -50.15242977 -120.7524255 9 
139 PLSCR1 MDFI -50.09653138 -284.4524951 20 
140 NOTCH1 NOTCH2 -50.05417387 -132.2017988 9 
141 ACTA1 ACTA2 -49.92697889 -121.5887173 8 
142 GEMIN5 DDX20 -49.65742117 -106.2810332 8 
143 PPFIA1 PPFIA2 -49.65089455 -111.7036483 8 
144 NIF3L1 FLJ22494 -49.41538383 -153.1918347 12 
145 RB1 RBL2 -49.35799053 -159.7627593 13 
146 TGFBR1 SMAD2 -49.22991515 -313.6395562 23 
147 PAG1 PTK2B -49.13577967 -106.1032354 11 
148 DLG1 DLG2 -49.11758986 -149.7428191 11 
149 SYK GRB2 -48.96440679 -216.4612199 19 
150 GRB2 VAV1 -48.95379374 -221.5131424 20 
151 GNAI1 GNAI3 -48.92562467 -156.5021062 11 
152 STAT3 STAT5A -48.87833789 -143.7916207 13 
153 GRIN2B GRIN2A -48.70997026 -103.2496301 9 
154 BCAR1 PXN -48.65494906 -144.6837174 13 
155 SNAP23 SNAP25 -48.54485032 -136.1281066 10 
156 DCN MMP9 -48.4240181 -121.169453 10 
157 LSM2 LSM6 -48.35487606 -97.64839637 8 
158 RB1 RBL1 -48.21283721 -171.297408 14 
159 MRAS RAP2A -48.13695391 -92.11190456 7 
160 SYK CBL -48.09739775 -146.6243912 14 
161 RXRA PPARG -48.03681755 -154.551442 12 
162 DCN TGFBI -47.93369554 -95.13917142 8 
163 GNAI2 GNAO1 -47.80939626 -154.1143633 11 
164 MCM3 MCM7 -47.73212946 -132.8259441 10 
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165 DCN C1QR1 -47.63175485 -113.3746534 9 
166 CDK4 CDK6 -47.39346181 -117.4577271 9 
167 GADD45A GADD45G -47.35497338 -93.59561967 8 
168 PPARA PPARG -47.31448046 -127.2745442 10 
169 LSM5 LSM2 -47.25803203 -97.64839637 8 
170 NUP214 NUP153 -47.25694418 -100.9688921 8 
171 RIPK1 TRADD -47.2113429 -117.5311184 10 
172 BIRC3 BIRC2 -47.12603232 -83.77493325 7 
173 BATF FOSL2 -47.12127462 -83.25986031 7 
174 GNA12 GNA13 -47.01864688 -138.531382 10 
175 SYK PIK3R1 -47.0063129 -166.6326524 16 
176 PLAT PLG -46.96960868 -133.6613215 10 
177 CDH1 CTNNB1 -46.90858967 -179.2859447 14 
178 GRB2 NCK1 -46.90800812 -231.1999571 19 
179 GRB2 CBL -46.9007666 -229.5719977 20 
180 ORC2L MCM7 -46.84619219 -132.9907331 10 
181 Rps27a Uhmk1 -46.84323227 -54.41756914 6 
182 GRB2 ZAP70 -46.84008345 -188.8756016 17 
183 FLJ32855 LNX -46.75233618 -123.3224073 11 
184 ABLIM1 TU3A -46.74843035 -85.3823523 8 
185 PPFIA2 PPFIA3 -46.6321971 -98.54875399 7 
186 TGFBR1 SMAD4 -46.56941628 -366.3543753 25 
187 RXRA THRB -46.41308504 -165.5102055 12 
188 ACVR2A ACVR2B -46.41127861 -110.1503806 8 
189 LSM3 LSM5 -46.40910277 -97.80254705 8 
190 PDGFRB EGFR -46.40310111 -162.0161989 15 
191 BCAR1 NEDD9 -46.24876461 -116.599624 11 
192 FXR2 LNX -46.24552497 -166.307615 14 
193 GNAI2 GNAI1 -46.21961531 -166.406671 12 
194 TNPO1 RANBP5 -46.05025162 -108.2216242 8 
195 JUN CEBPB -46.03232224 -163.504687 15 
196 LSM4 LSM5 -45.64641909 -97.9456479 8 
197 LSM3 LSM2 -45.45440799 -97.96960114 8 
198 TGFBR3 ENG -45.42849633 -82.7769275 7 
199 PEPP-2 RBPMS -45.36250418 -157.0131503 12 
200 NCOA1 NRIP1 -45.25772539 -131.2515547 12 
201 NDP52 DIPA -45.24092977 -236.7683123 18 
202 NCOA2 PPARBP -45.10586824 -101.2283063 9 
203 SIT1 PAG1 -45.03108659 -68.7234239 7 
204 ORC1L MCM3 -44.95708047 -105.1465529 8 
205 HABP2 SERPINE2 -44.89732213 -76.79095267 6 
206 PTPN11 CRKL -44.78490422 -156.8651716 14 
207 LSM4 LSM2 -44.69186048 -98.11270198 8 
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208 HRAS RAP1A -44.65606489 -128.1956568 10 
209 JUN JUNB -44.63141161 -129.3848887 11 
210 TGFBR1 TGFBR2 -44.56273839 -174.3312409 14 
211 PIK3R1 PIK3R2 -44.49201549 -114.1243101 11 
212 PIK3R1 FYN -44.2701179 -232.9912143 20 
213 CCR2 CCR5 -44.14390473 -110.3012698 8 
214 AP2M1 AP1M1 -43.94719372 -117.6375598 9 
215 CDC42 RHOA -43.85316884 -200.1685715 14 
216 LSM3 LSM4 -43.84660373 -98.26685266 8 
217 LSM3 LSM7 -43.84660373 -99.12430289 8 
218 MMP9 MATN2 -43.76638644 -97.93373905 8 
219 EFEMP2 KRTAP4-12 -43.76009548 -178.2902063 13 
220 VAV1 ZAP70 -43.73581462 -136.522431 12 
221 STAT5B STAT5A -43.61607016 -100.7888124 9 
222 Rasd2 Rps27a -43.509397 -54.41756914 6 
223 Rasd2 Fbxo3 -43.509397 -54.65430411 6 
224 Rasd2 Sqstm1 -43.509397 -55.14657866 6 
225 Rasd2 Map2k3 -43.509397 -53.1824134 6 
226 Rasd2 Uhmk1 -43.509397 -54.41756914 6 
227 Rasd2 Rhod -43.509397 -55.7396668 6 
228 DCN FBLN2 -43.42110213 -112.3362812 9 
229 PIK3R1 LYN -43.25809006 -199.2928279 17 
230 PTPN11 SYK -43.00462897 -149.9651422 14 
231 APEX2 TU3A -42.95178206 -71.96030807 7 
232 VLDLR LRP8 -42.9507326 -84.28501423 6 
233 RPP25 POP5 -42.9507326 -87.80362146 6 
234 RPP25 RPP30 -42.9507326 -87.80362146 6 
235 POP5 RPP30 -42.9507326 -87.80362146 6 
236 DCN MATN2 -42.83346747 -97.93373905 8 
237 ACVR1 SMAD4 -42.72020889 -240.1710342 17 
238 GAB2 SHC1 -42.6974178 -112.0751914 11 
239 RXRA RXRB -42.68817061 -130.8295077 10 
240 NCOA1 RXRA -42.63524817 -170.8421429 14 
241 HDAC3 HDAC2 -42.61819069 -158.2345068 13 
242 TBP TAF1 -42.59805866 -137.9181026 12 
243 OSM HABP2 -42.40996916 -76.79095267 6 
244 MAPK8IP1 MAPK8IP2 -42.33772675 -83.34262178 7 
245 BMP2 BMP7 -42.33582328 -89.46033915 7 
246 GADD45B GADD45A -42.33582328 -83.22242956 7 
247 GNAI1 GNAQ -42.31927231 -161.3585908 11 
248 SNX1 SNX2 -42.20077893 -81.12426297 7 
249 ERCC3 GTF2H5 -42.07141913 -100.6980051 7 
250 MAP3K14 TRAF3IP2 -42.07141913 -75.87139392 7 
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251 MYOD1 TCF3 -41.94784723 -134.3091363 11 
252 CASP8 CFLAR -41.93916853 -113.6687053 9 
253 PIK3R1 LCK -41.91302113 -184.8567086 16 
254 JAK1 JAK3 -41.82955924 -117.902316 10 
255 DDIT3 BATF -41.7367615 -99.22834816 8 
256 C1QR1 MMP9 -41.72314951 -100.4494174 8 
257 KRT15 USHBP1 -41.69024654 -158.4353022 12 
258 DLG1 DLG3 -41.65494862 -135.4901292 10 
259 E2F2 E2F3 -41.56375877 -78.20255709 6 
260 BMP7 GDF5 -41.49286277 -71.03511552 6 
261 SIP1 SFRS2IP -41.49286277 -77.52434331 6 
262 FN1 DCN -41.46084085 -135.7774582 11 
263 PPFIA1 PPFIA3 -41.44213051 -99.6191954 7 
264 DIPA HOOK2 -41.41509206 -153.9566021 12 
265 SMURF2 SMURF1 -41.39619496 -220.2378639 14 
266 SFRS1 SFRS2 -41.38096387 -112.9666444 8 
267 VAV1 CBL -41.35790865 -138.5413097 13 
268 DNM1 SYNJ1 -41.34420166 -86.97828944 7 
269 SNRPE SNRPD2 -41.32490269 -96.06384734 7 
270 LSM5 LSM6 -41.32490269 -84.37378467 7 
271 ARF1 ARF6 -41.30877327 -111.7981418 8 
272 CASP8 FADD -41.29842529 -131.406081 10 
273 SRC PLCG1 -41.21726699 -189.9434317 17 
274 LYN LCK -41.18164688 -162.2855551 14 
275 SRC LCK -41.1732206 -183.5990962 16 
276 PTK2B PXN -41.01939063 -145.9634317 13 
277 RAP1A RAP2A -40.8660863 -92.39958664 7 
278 DIPA USHBP1 -40.78388281 -195.9356015 15 
279 HABP2 MATN2 -40.70766738 -76.79095267 6 
280 MYOD1 MYOG -40.62940142 -91.27315733 8 
281 PIK3R1 CRKL -40.57375767 -156.0399911 14 
282 SNTA1 SNTB2 -40.55130524 -103.4834277 7 
283 C1QR1 MATN2 -40.55130524 -88.12201829 7 
284 GHR EPOR -40.54843776 -92.54024858 9 
285 RPP25 RPP38 -40.46609791 -88.34261796 6 
286 POP5 RPP38 -40.46609791 -88.34261796 6 
287 RPP30 RPP38 -40.46609791 -90.28852811 6 
288 OSM SERPINE2 -40.46446692 -76.79095267 6 
289 TGFBI MMP9 -40.46367871 -83.64468148 7 
290 PTPN6 GRB2 -40.37656558 -215.1490247 19 
291 HDAC1 HDAC3 -40.29652281 -184.5879805 15 
292 BMPR1A BMPR2 -40.23924629 -93.96468397 7 
293 PXN NEDD9 -40.2361581 -113.3121523 11 
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294 NCK2 NCK1 -40.20086252 -134.6177707 11 
295 RGS16 RIC8 -40.17773637 -67.38652981 6 
296 GRB2 LCP2 -40.17518002 -143.5999216 13 
297 ESR1 PPARA -40.15293346 -139.6695433 12 
298 SYK SHC1 -40.09195087 -153.7464221 14 
299 PIK3R1 SOCS1 -40.06668637 -129.5450323 12 
300 SMAD4 SMURF2 -40.04433175 -210.6740511 15 
301 PIK3R1 PTPN6 -39.93165164 -180.291024 16 
302 VAV1 FYN -39.88833982 -164.0926823 15 
303 LSM3 LSM6 -39.85775044 -84.69498943 7 
304 SNX6 SNX2 -39.85775044 -83.82843161 7 
305 CCND3 CCND2 -39.84162117 -90.72353943 7 
306 SRC PTK2 -39.82567764 -172.8450731 16 
307 GRB2 LYN -39.74804755 -222.7113672 19 
308 NRBF2 CGI-63 -39.73158422 -55.92972196 5 
309 MNAT1 CCNH -39.67665305 -85.02417441 7 
310 TRAF5 TRAF6 -39.59479632 -117.835573 9 
311 SHB SHC1 -39.57382389 -121.6037075 11 
312 RASIP1 RALGDS -39.39548099 -76.14064973 6 
313 C1QR1 HABP2 -39.38977137 -76.79095267 6 
314 PDGFRB PDGFRA -39.38885079 -106.2921215 9 
315 CRK CRKL -39.36474033 -131.4257445 11 
316 LSM4 LSM6 -39.22873411 -84.83809028 7 
317 LSM7 LSM6 -39.22873411 -84.83809028 7 
318 TU3A ZNF638 -39.22873411 -73.58197839 7 
319 NCOA1 TRIP4 -39.08813372 -88.31539245 9 
320 VAV1 LYN -38.96454176 -145.5439083 13 
321 VAV1 ITK -38.88788498 -95.53901474 9 
322 PIK3R1 CBL -38.87133268 -159.2201208 15 
323 CHUK IKBKG -38.86245192 -109.922838 9 
324 MPP6 MPHOSPH6 -38.82933948 -89.39471023 6 
325 IL2RB IL2RG -38.78349477 -100.1553455 8 
326 SERPINE2 MATN2 -38.76162185 -76.79095267 6 
327 LSM1 LSM7 -38.74995345 -102.4421187 8 
328 MYOD1 MYF5 -38.74757995 -86.57241694 7 
329 NCOR1 HDAC1 -38.6291783 -153.4759068 13 
330 JUN ATF2 -38.55288725 -122.141834 11 
331 SOCS1 SOCS3 -38.48629283 -92.27214114 8 
332 PTPN6 CRKL -38.46424811 -135.5828818 12 
333 RBBP4 HDAC2 -38.45389791 -103.3187214 9 
334 PTPN11 SOCS3 -38.35768563 -111.7661621 10 
335 LSM5 LSM7 -38.35721042 -85.02041183 7 
336 JAK2 EPOR -38.35610561 -111.6535173 11 
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337 BCAR1 CBL -38.34818087 -113.6672268 11 
338 ACVR1B ACVR2B -38.21194941 -95.01677625 7 
339 JAK2 GHR -38.19468926 -101.7545324 10 
340 RB1 HDAC1 -38.17580263 -202.9810522 17 
341 FN1 C1QR1 -38.15340304 -113.3746534 9 
342 KRT19 KRT15 -38.10828079 -120.1304474 9 
343 MCM3 MCM2 -38.06647217 -104.5689186 8 
344 IGF1R IRS1 -38.05870836 -108.2068021 10 
345 PTPN12 PTK2 -38.03029447 -97.40838181 9 
346 ARCN1 COPE -37.93982475 -67.78837801 5 
347 AFTIPHILIN AP1GBP1 -37.93982475 -68.10316201 5 
348 Rab38 Map2k3 -37.93982475 -44.04891418 5 
349 Rhobtb1 Rps27a -37.93982475 -45.96449121 5 
350 Rhobtb1 Fbxo3 -37.93982475 -45.96449121 5 
351 Rhobtb1 Uhmk1 -37.93982475 -45.96449121 5 
352 Rhoj Rhod -37.93982475 -45.28406991 5 
353 Rps27a Rhoj -37.93914536 -45.28406991 5 
354 Uhmk1 Rhoj -37.93914536 -45.28406991 5 
355 ZAP70 CBL -37.91376014 -119.9245798 11 
356 JAK2 GRB2 -37.89879538 -199.208469 18 
357 SMAD2 SMURF1 -37.84663713 -245.4812714 16 
358 VAV1 SHC1 -37.80246512 -146.7413383 14 
359 YWHAH YWHAB -37.67115933 -124.2123049 10 
360 TRAF1 TRAF5 -37.66196924 -104.3042011 8 
361 GHR IL2RB -37.6535237 -81.44727819 8 
362 FBLN2 MATN2 -37.62904187 -86.60267342 7 
363 CCR3 CCBP2 -37.58415763 -102.8772919 7 
364 LSM7 LSM2 -37.58225339 -85.18746592 7 
365 CBX5 CBX3 -37.45101917 -96.06384734 7 
366 MYF5 TCF4 -37.44970757 -71.24928561 6 
367 SNTA1 SNTB1 -37.44481328 -84.86445954 6 
368 C1QR1 SERPINE2 -37.44481328 -76.79095267 6 
369 ORC2L MCM2 -37.43143898 -102.846638 8 
370 TGFBI MATN2 -37.37519209 -71.31728241 6 
371 MEP50 SMN2 -37.37519209 -81.31323519 6 
372 COPG COPG2 -37.37274511 -81.61758432 6 
373 SNX1 SNX4 -37.37274511 -68.86960731 6 
374 SNX2 SNX4 -37.37274511 -67.84650257 6 
375 CDC2 CCNB1 -37.36662133 -104.0034713 9 
376 GRB2 SOCS1 -37.32588335 -151.7299828 13 
377 GAB1 SHC1 -37.32014814 -103.9326095 10 
378 KIT GAB2 -37.23916225 -78.5627139 8 
379 ORC4L MCM7 -37.19693349 -89.75000862 7 
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380 DNMT3B DNMT3A -37.06367795 -75.51782783 6 
381 YWHAH YWHAE -37.01500475 -124.0001303 10 
382 NCOA1 ESR1 -37.0092193 -161.0801637 14 
383 FBLN2 HABP2 -37.00446152 -76.79095267 6 
384 WAS CBL -36.98082325 -103.8072983 10 
385 CCR5 CCR1 -36.95819592 -101.3368469 7 
386 SYK LYN -36.79947833 -144.6458661 12 
387 PTPN11 LYN -36.79710806 -165.9931712 14 
388 PTPN11 VAV1 -36.71246718 -137.8453417 13 
389 CORT SST -36.68570291 -77.67344698 5 
390 GAB3 CSF1R -36.68231702 -62.32889307 6 
391 HLA-A HLA-B -36.67905416 -81.31974988 6 
392 BATF ATF3 -36.67905416 -69.65580396 6 
393 GNAI3 GNAO1 -36.66530744 -113.2407623 8 
394 THRAP4 PPARBP -36.63476315 -65.60952835 6 
395 KIT EPOR -36.63165599 -95.0663538 9 
396 XRCC5 XRCC6 -36.59489555 -94.9311125 8 
397 IL6ST LIFR -36.59474601 -95.92593859 7 
398 BCL3 TRIP4 -36.47599033 -71.03108651 7 
399 JAK1 IL2RB -36.39720697 -94.26662965 9 
400 JAK2 PTPN6 -36.33127453 -145.5425149 13 
401 PDGFRB INSR -36.33042752 -118.0134758 10 
402 HIST3H3 HIST2H2BE -36.31673665 -97.46379232 7 
403 JAK1 VAV1 -36.30137608 -119.24112 11 
404 OSM MATN2 -36.27644439 -76.79095267 6 
405 MMP9 HABP2 -36.26666352 -76.79095267 6 
406 GAB1 GAB2 -36.26267605 -72.22069688 7 
407 LSM4 LSM7 -36.26267605 -85.48471744 7 
408 TRAF2 TRAF6 -36.20107542 -197.1283011 15 
409 PTK2B CRKL -36.19897285 -110.8158048 11 
410 PTPN11 SRC -36.196943 -173.2372823 16 
411 IGSF1 INHBC -36.14752183 -61.74378984 5 
412 ARPC3 ARPC2 -36.14752183 -71.70218514 5 
413 ARPC3 ARPC4 -36.14752183 -71.70218514 5 
414 ARPC2 ARPC4 -36.14752183 -71.70218514 5 
415 Rps27a Fbxo3 -36.14752183 -45.96449121 5 
416 Rps27a Sqstm1 -36.14752183 -46.45676576 5 
417 Rps27a Map2k3 -36.14752183 -44.4926005 5 
418 Rps27a Rhod -36.14752183 -45.28406991 5 
419 Fbxo3 Sqstm1 -36.14752183 -46.69350074 5 
420 Fbxo3 Map2k3 -36.14752183 -44.72933548 5 
421 Fbxo3 Uhmk1 -36.14752183 -45.96449121 5 
422 Sqstm1 Map2k3 -36.14752183 -45.22161003 5 
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423 Sqstm1 Uhmk1 -36.14752183 -46.45676576 5 
424 Map2k3 Uhmk1 -36.14752183 -44.4926005 5 
425 Uhmk1 Rhod -36.14752183 -45.28406991 5 
426 FYN CRKL -36.09941856 -144.5021595 13 
427 PTK2 PDGFRB -36.09474132 -104.3050692 11 
428 TGFBI C1QR1 -36.06354996 -73.83296072 6 
429 SYK PLCG1 -35.94622955 -125.7579613 12 
430 TRAF2 DIPA -35.90885608 -283.1926128 22 
431 GTF2E2 GTF2E1 -35.7842048 -85.02246909 7 
432 ESR1 HNF4A -35.76439277 -119.2556816 10 
433 IKBKB RIPK1 -35.73511568 -90.29451606 8 
434 CDC2 CDK2 -35.72524914 -125.8585826 10 
435 PARD6G PARD6A -35.70623253 -57.17807582 5 
436 TNFRSF19 TNFRSF11A -35.70623253 -53.47486974 5 
437 BAK1 PMAIP1 -35.70419407 -60.61054889 5 
438 TFDP1 TFDP2 -35.70419407 -66.5474495 5 
439 Rasd2 Rab38 -35.70419407 -44.04891418 5 
440 Rasd2 Rhobtb1 -35.70419407 -45.96449121 5 
441 Rasd2 Rhoj -35.70419407 -45.28406991 5 
442 Rasd2 Smad3 -35.70419407 -45.86548616 5 
443 Rasd2 Rras2 -35.70419407 -47.3351771 5 
444 Rasd2 Stat1 -35.70419407 -45.92794604 5 
445 COL4A2 COL1A2 -35.68840138 -82.69612751 7 
446 VIL2 MSN -35.68291003 -106.6973835 8 
447 PTPRC PAG1 -35.68291003 -79.63800386 8 
448 DCN HABP2 -35.61010368 -76.79095267 6 
449 PTPN6 LYN -35.58471818 -149.3415021 13 
450 RELA JUN -35.582208 -156.1129099 15 
451 INHBA INHBB -35.58125809 -78.6355371 6 
452 GRB2 INSR -35.57112982 -171.0766973 15 
453 PIK3R1 PTK2B -35.53017551 -135.8205498 14 
454 RAD9A HUS1 -35.49931139 -75.89204162 6 
455 JAK1 PTPN11 -35.48636942 -131.213017 12 
456 CD22 CBL -35.43098247 -77.42968386 8 
457 CCND1 CCND2 -35.41841277 -90.72353943 7 
458 YWHAH SMARCE1 -35.41841277 -72.80221266 7 
459 NFKB1 NFKB2 -35.38845238 -101.7668362 8 
460 DNM1 WASL -35.29172923 -85.57242498 7 
461 IKBKB IKBKG -35.28503947 -97.95715952 8 
462 SMAD4 SMURF1 -35.19121876 -263.1069878 17 
463 RXRA PPARA -35.1706672 -124.9050345 10 
464 LYN HCK -35.13675288 -127.3651279 10 
465 CASP3 CASP7 -35.07561256 -107.0499034 8 
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466 FBLN2 SERPINE2 -35.06018402 -76.79095267 6 
467 GRB2 GRAP2 -35.03829526 -159.0576748 13 
468 RARA ESR1 -35.0124807 -144.9254486 12 
469 MEP50 DDX20 -34.99365295 -81.31323519 6 
470 GAB2 GAB3 -34.98794177 -55.64576093 6 
471 ACVR1B INHBB -34.96181113 -77.19315327 6 
472 C1QR1 OSM -34.96181113 -76.79095267 6 
473 DAZAP2 RNF11 -34.9335871 -126.1961635 9 
474 CCL8 CCL7 -34.89489481 -63.50804216 5 
475 ARHGEF12 ARHGEF11 -34.89489481 -63.18994706 5 
476 LILRB2 LILRB1 -34.89421532 -68.16645686 5 
477 GGA3 GGA1 -34.89421532 -68.53818941 5 
478 TOB1 ZNF8 -34.89258419 -48.97444407 5 
479 USP7 TNFRSF19 -34.89258419 -53.47486974 5 
480 PIK3R1 ZAP70 -34.77856073 -128.0593263 12 
481 RAF1 BRAF -34.72406764 -92.8809925 8 
482 KIAA0980 HOOK2 -34.71540429 -102.1030953 8 
483 JAK2 SHC1 -34.6932362 -154.7227013 14 
484 PECAM1 TRPV4 -34.68001391 -60.94693657 6 
485 BLNK CBLB -34.66747603 -73.09234363 7 
486 TF IGF1 -34.66741533 -88.94045496 6 
487 KIAA0408 TU3A -34.66461869 -72.34650036 7 
488 PTPN6 PLCG1 -34.65915131 -139.2295527 13 
489 CSK FYN -34.57068818 -126.9290328 11 
490 PLCG1 FYN -34.56321283 -168.0280133 15 
491 ZBTB16 HDAC3 -34.52712025 -127.3560678 11 
492 RAP1A MRAS -34.51739407 -78.32921827 6 
493 SMAD2 SMAD1 -34.39386332 -145.4455218 12 
494 FN1 COL1A1 -34.38279739 -131.4316458 10 
495 SIN3A HDAC9 -34.38188955 -90.63924088 8 
496 RB1 SP1 -34.38086977 -160.3971522 14 
497 SLC9A3R1 SLC9A3R2 -34.3603185 -111.7973943 8 
498 SRC RASA1 -34.34859508 -143.5616914 13 
499 MMP9 SERPINE2 -34.32265839 -76.79095267 6 
500 BGN DCN -34.31263744 -85.13127648 7 
501 CCR5 CCR3 -34.30406426 -102.8772919 7 
502 PECAM1 CBL -34.29840109 -88.24072021 9 
503 POU2F1 POU2F2 -34.22793856 -69.96311341 6 
504 BLNK LCP2 -34.20903362 -78.37354623 7 
505 TBL1X TBL1XR1 -34.19875724 -62.58438979 5 
506 CDC5L CCDC5 -34.19875724 -60.05789863 5 
507 RAC1 RAC2 -34.11034585 -112.3971561 8 
508 S100A1 S100B -34.0926579 -102.3084425 7 
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509 ORC4L ORC2L -34.0888758 -76.25991841 6 
510 EGFR ERBB3 -34.07603135 -121.7110921 10 
511 CCND1 CCND3 -34.06321245 -100.0779632 8 
512 FOS CEBPB -34.05116493 -114.8295819 10 
513 CCR3 CCR1 -34.04647284 -89.34592007 6 
514 PTPN11 SOCS1 -34.01472826 -103.2900617 10 
515 MLLT4 RASIP1 -33.98595884 -76.14064973 6 
516 NEDD4 NEDD4L -33.98550548 -83.6034998 6 
517 ACVR1 ACVR2A -33.95679771 -109.0517684 8 
518 LYN CRKL -33.9558387 -125.7169321 11 
519 MAPK1 MAPK14 -33.92044979 -160.6026348 11 
520 ORC4L ORC5L -33.91284246 -61.96298679 5 
521 HUS1 RAD1 -33.91284246 -71.1701573 5 
522 SCNN1B SCNN1G -33.91284246 -66.6742012 5 
523 MAP2K3 MAP2K6 -33.91284246 -67.35821776 5 
524 ZNFN1A1 ZNFN1A4 -33.89055406 -75.36823352 6 
525 MBD2 MBD3 -33.87814276 -85.45156742 6 
526 NUP153 RANBP2 -33.87814276 -73.80201592 6 
527 FXR2 FLJ32855 -33.87642856 -98.99838339 9 
528 GRB2 PTK2B -33.83177756 -160.7430491 16 
529 GHR IGF1R -33.82987341 -88.56633783 8 
530 HDAC4 HDAC9 -33.77457789 -81.91910026 7 
531 YWHAZ YWHAQ -33.69046478 -129.652023 9 
532 DCN SERPINE2 -33.66637099 -76.79095267 6 
533 NCOA1 JUN -33.65774353 -140.5353335 13 
534 CREBBP JUN -33.63178649 -165.8707259 15 
535 CBX1 CBX5 -33.60652711 -93.69535104 7 
536 PTPN12 PTK2B -33.5598132 -85.8268805 8 
537 ESR1 PPARG -33.54224535 -124.295377 10 
538 APP C1QR1 -33.52055199 -102.9786486 8 
539 ZAP70 LCP2 -33.51980547 -83.83132016 8 
540 PIK3R1 PTK2 -33.45295382 -143.4695103 14 
541 PTPN11 CSK -33.45225403 -107.972887 10 
542 NCOR2 HDAC3 -33.43088621 -123.7613897 10 
543 DIPA MDFI -33.41648469 -275.3632229 19 
544 LAT PLCG1 -33.39324909 -104.2851291 9 
545 SMARCA4 SMARCA2 -33.36340926 -73.89034773 6 
546 BCL6 ZBTB16 -33.29316751 -92.97564178 8 
547 NCK1 CRKL -33.27477166 -115.4856006 10 
548 JAK2 SYK -33.25824935 -111.7408158 11 
549 RARA THRA -33.23045779 -98.03845869 8 
550 CCNA2 CCNE1 -33.20098475 -86.19745052 7 
551 PTK2B PDGFRB -33.18243816 -94.18335239 10 
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552 JAK2 TYK2 -33.15466294 -97.43908829 9 
553 GRB2 PLCG2 -33.15358051 -133.4569799 11 
554 LAT LCP2 -33.104406 -78.46792829 7 
555 INHBC INHBB -33.1034073 -61.13765404 5 
556 TNFRSF10A TNFRSF10B -33.10136856 -60.52826152 5 
557 REM1 CDC25B -33.05702283 -54.28692389 5 
558 RABEP1 AFTIPHILIN -33.05226513 -68.10316201 5 
559 DIPA KRTAP4-12 -33.02838293 -233.4692543 17 
560 GRB2 ERBB2 -33.02799709 -150.9252139 14 
561 PIK3R1 TYK2 -32.99424352 -107.4069855 10 
562 APEX2 RIBC2 -32.94806323 -61.83105909 6 
563 LCK ZAP70 -32.90135464 -116.0301879 10 
564 COL2A1 COL1A1 -32.87620443 -100.3510895 8 
565 SYK PTPN6 -32.86554283 -118.7756582 11 
566 RIPK1 RIPK2 -32.79579325 -77.69960059 7 
567 SHC1 CBL -32.75931493 -144.5900294 13 
568 FN1 MMP9 -32.73817565 -111.3577322 9 
569 GNAS GNAQ -32.73806062 -113.6733988 8 
570 SIN3A HDAC2 -32.71826037 -120.9104291 10 
571 YWHAZ YWHAH -32.6937727 -130.1203729 10 
572 ATF3 FOSL2 -32.66048741 -57.88802068 5 
573 SMN1 LSM2 -32.65337462 -87.60111767 7 
574 FYN LCP2 -32.6525298 -113.9976768 10 
575 KRT15 NDP52 -32.6442493 -143.3894736 11 
576 BMPR1B SMURF1 -32.63634858 -194.6474246 13 
577 NCOA3 NCOA2 -32.61165933 -81.32546031 7 
578 NCOA1 TIF1 -32.59360525 -97.73605227 9 
579 SHC1 STAT5A -32.59325557 -115.735683 11 
580 OSM FBLN2 -32.58588828 -76.79095267 6 
581 NUP98 NUP153 -32.56677358 -76.40998266 6 
582 CD40 TNFRSF19 -32.56607728 -53.47486974 5 
583 CD4 LCK -32.55970867 -122.5366485 10 
584 FN1 TGFBI -32.55353135 -85.32745066 7 
585 NOTCH1 NOTCH3 -32.53688296 -85.4482858 6 
586 CD9 CD81 -32.5052127 -82.62493258 6 
587 NCOA1 PPARGC1A -32.50422281 -94.50659117 8 
588 ZBTB16 NRIP1 -32.49577075 -87.90110711 9 
589 EMP3 KCNQ2 -32.4374787 -47.02795198 4 
590 CCL11 CCL13 -32.4374787 -50.19981384 4 
591 RPP14 RPP21 -32.4374787 -55.74247697 4 
592 Arhgef7 Trim35 -32.4374787 -35.40988928 4 
593 Pftk1 Nat5 -32.4374787 -36.83099199 4 
594 MAFF MAFG -32.41039613 -72.91127304 5 
 - 102 - 
 
595 BMP7 BMP6 -32.40767763 -60.47934284 5 
596 TNFRSF14 TNFRSF17 -32.40767763 -58.12704277 5 
597 SYK PLCG2 -32.37197104 -95.18028599 8 
598 MLLT4 RALGDS -32.365557 -92.15692824 7 
599 RASA1 SHC1 -32.28121773 -125.3254865 12 
600 PTPN11 PLCG1 -32.20979568 -141.9619983 13 
601 MAP2K4 MAP2K7 -32.18825561 -79.73741389 6 
602 TU3A KIAA1267 -32.18825561 -58.04879702 6 
603 MMP9 FBLN2 -32.18142273 -86.60267342 7 
604 RARA PPARG -32.18018211 -95.65850212 8 
605 STAT3 STAT1 -32.15265248 -113.9395696 10 
606 PTK2B CBL -32.14192738 -103.8014498 11 
607 BCL6 HDAC3 -32.13667985 -92.38746555 8 
608 HSPA5 CANX -32.12555011 -112.4662423 8 
609 PLCG1 LCP2 -32.01650369 -100.9770405 9 
610 BCAR1 CRK -32.00183808 -104.8603711 9 
611 ORC4L MCM2 -31.99167383 -74.39574636 6 
612 CHUK MAP3K14 -31.96295261 -83.05833272 7 
613 CSF3R PTK2B -31.95792521 -66.47528197 7 
614 HNF4A THRB -31.88925458 -87.63468639 7 
615 OSM MMP9 -31.85054094 -76.79095267 6 
616 TLR2 TLR4 -31.85050877 -74.22758315 5 
617 SMAD7 SMAD6 -31.84156256 -79.39663943 6 
618 ADAM15 CBL -31.80737585 -70.1869827 7 
619 MAP1A CRIPT -31.800998 -54.98866917 5 
620 BLNK CBL -31.78599342 -84.86274172 8 
621 PTPN11 GRB10 -31.77781584 -95.46808621 9 
622 CANX CALR -31.77660889 -103.5384027 8 
623 RBBP7 RBBP4 -31.72421716 -57.07161006 5 
624 KCNJ12 ATP2B4 -31.71741906 -54.58546523 5 
625 MCM10 MCM3 -31.70587608 -91.39203747 7 
626 CASP8 RIPK1 -31.70415659 -103.5002758 8 
627 AFAP HABP4 -31.68006612 -57.53713921 5 
628 SNRPD3 SNRPD1 -31.68006612 -66.19077455 5 
629 PTK2B LCK -31.67173124 -115.2096598 11 
630 FBLN2 FBLN1 -31.66388593 -73.54489411 6 
631 GRB2 CRK -31.6597022 -167.808353 14 
632 COL4A2 COL1A1 -31.64751933 -85.75866846 7 
633 COL4A1 COL1A1 -31.64751933 -86.78317277 7 
634 VIM KRT15 -31.63073262 -126.2457415 10 
635 TRAF2 IKBKG -31.63064588 -138.4271118 11 
636 BRCA1 RB1 -31.61476877 -156.3847421 14 
637 PTK2B FYN -31.59120717 -140.520247 13 
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638 JAK2 VAV1 -31.54245229 -116.4323945 11 
639 TRAF1 TRAF6 -31.49650211 -111.9558318 9 
640 PTPN11 EPOR -31.48659412 -105.5320496 10 
641 PIK3R1 EGFR -31.47494251 -162.1650224 16 
642 GRB2 PTK2 -31.44723677 -166.9434391 16 
643 PTPN11 CRK -31.42206663 -117.0050637 11 
644 PRKAR2A PRKAR2B -31.41622061 -88.78857443 6 
645 TNFAIP3 MAP3K14 -31.39002439 -64.21578463 6 
646 SOS1 PDGFRB -31.38561486 -78.17246333 8 
647 REM1 BAD -31.34952371 -54.28692389 5 
648 EPOR PAG1 -31.33706949 -66.01767275 7 
649 PTPRC CD5 -31.32026466 -75.49957905 7 
650 JAK3 IL2RB -31.29465117 -77.59721877 7 
651 CD82 CD81 -31.28412446 -80.29480992 6 
652 IGSF1 INHBA -31.2655359 -61.74378984 5 
653 INHBC INHBA -31.2655359 -61.74378984 5 
654 CCL5 CCL8 -31.26145759 -62.40204976 5 
655 RABEP1 AP1GBP1 -31.26145759 -68.10316201 5 
656 JAK1 STAT3 -31.23779968 -114.540012 10 
657 FYN CBL -31.22107532 -147.1857299 13 
658 PIK3R1 RASA1 -31.19756881 -138.9056496 12 
659 PTK2 SHC1 -31.19518894 -134.7707299 13 
660 DCN OSM -31.18582016 -76.79095267 6 
661 HOXA1 CATSPER1 -31.15559461 -54.05257076 5 
662 NOTCH2 NOTCH3 -31.15559461 -73.86678449 5 
663 PTPN11 TYK2 -31.14416544 -97.9043831 9 
664 PRKDC XRCC6 -31.12227761 -95.81309889 8 
665 SOS1 CBLB -31.03169926 -70.98504121 7 
666 RBMX KHDRBS3 -31.02959518 -75.51382838 6 
667 BIRC2 BIRC4 -31.02959518 -79.79049898 6 
668 FGF1 FGF2 -31.02959518 -79.49214238 6 
669 BAD BAX -31.02633054 -75.6748186 6 
670 LMO2 LMO1 -30.99305818 -74.08992804 5 
671 SIN3A SIN3B -30.97066433 -84.69341608 7 
672 SFRS1 U2AF2 -30.93942936 -100.3646354 7 
673 TIF1 PPARBP -30.93657046 -75.10238772 7 
674 DLG4 GRIN2B -30.93432139 -114.6437909 9 
675 DVL2 FXR2 -30.8953341 -116.6308025 10 
676 COPG COPB -30.88277562 -80.97005152 6 
677 RBBP4 DNMT1 -30.87851954 -66.54218575 6 
678 RASA1 FYN -30.87845917 -134.937216 12 
679 IL16 INADL -30.87706211 -88.44059837 6 
680 BCL2A1 MCL1 -30.86954393 -70.96251794 5 
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681 HLA-B HLA-G -30.86954393 -68.39451381 5 
682 MEP50 GEMIN5 -30.86954393 -66.90639459 5 
683 RGS16 RGS19 -30.86954393 -61.16342782 5 
684 LIN7B LIN7A -30.86954393 -57.12851243 5 
685 PER3 PER1 -30.86886426 -70.13323858 5 
686 USP7 TNFRSF11A -30.86886426 -53.47486974 5 
687 CASP8 CASP10 -30.85105869 -94.78382841 7 
688 GLI1 GLI2 -30.82804079 -58.93718969 4 
689 Rhebl1 Rhobtb1 -30.82804079 -36.83099199 4 
690 Rhebl1 Rhoj -30.82804079 -36.83099199 4 
691 Arhgef7 Smad3 -30.82804079 -35.40988928 4 
692 
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Rik Rhoj -30.82804079 -35.47234916 4 
693 Trim35 Smad3 -30.82804079 -35.40988928 4 
694 Smad2 Smad3 -30.82804079 -36.73198694 4 
695 KCNQ5 EMP3 -30.82749731 -47.02795198 4 
696 KCNQ5 KCNQ2 -30.82749731 -47.02795198 4 
697 ZNF8 ZFHX1B -30.82749731 -40.52136615 4 
698 PTCH PTCH2 -30.82749731 -67.36095093 4 
699 POP1 RPP14 -30.82749731 -55.74247697 4 
700 POP1 RPP21 -30.82749731 -55.74247697 4 
701 Rab38 Arhgef6 -30.82749731 -35.59583626 4 
702 Rhobtb1 Pftk1 -30.82749731 -36.83099199 4 
703 Rhobtb1 Nat5 -30.82749731 -36.83099199 4 
704 Rhoj Ilkap -30.82749731 -36.15057069 4 
705 JAK2 PTK2B -30.77981862 -108.2485729 11 
706 ACVR1B INHBC -30.7754058 -61.91084393 5 
707 GGA2 GGA1 -30.7754058 -72.97296661 5 
708 SYK PTK2B -30.66180183 -95.26766814 10 
709 E2F1 E2F2 -30.65974521 -78.48187091 6 
710 GRB2 BLNK -30.65670975 -120.3327043 10 
711 TCF4 TCF3 -30.64875469 -83.94407337 7 
712 EPOR PTK2B -30.60277689 -84.59039467 9 
713 RPA2 RPA1 -30.59509422 -79.54375183 6 
714 ORC1L ORC2L -30.59509422 -77.83249473 6 
715 PTPN11 PTPN12 -30.59238456 -78.21043474 8 
716 IRS2 VAV3 -30.59101314 -56.64860035 6 
717 CEBPG BATF -30.59101314 -77.28930497 6 
718 PML JUN -30.59048666 -127.5630773 12 
719 EP300 JUN -30.58288398 -154.1086094 14 
720 ITK PLCG1 -30.57818452 -86.38077167 8 
721 TNFRSF1A TRPC4AP -30.57769724 -66.07590436 6 
722 IPO7 RANBP5 -30.55176989 -71.48477226 5 
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723 STAM STAM2 -30.55176989 -60.90738284 5 
724 SNTB2 SNTB1 -30.54905102 -71.55623122 5 
725 SP1 SP3 -30.53379597 -82.46918274 7 
726 ZAP70 CD3Z -30.5130943 -96.66278047 8 
727 PPARG THRB -30.50973846 -87.58117972 7 
728 CD22 LCP2 -30.50396706 -59.23466246 6 
729 PPARBP NR0B2 -30.49743689 -62.16398723 6 
730 FLJ32855 KIAA1267 -30.49743689 -60.12905523 6 
731 FLJ32855 C16orf48 -30.49743689 -57.60455668 6 
732 HSPCA TEBP -30.47408992 -98.7493154 8 
733 EPOR IGF1R -30.46509596 -87.499932 8 
734 RARA PPARA -30.42990791 -99.84815686 8 
735 LCK CD3Z -30.39640064 -112.7030258 9 
736 PTK2 CRKL -30.38170107 -100.8116102 10 
737 NRBF2 PPARBP -30.37041296 -55.92972196 5 
738 CGI-63 PPARBP -30.37041296 -55.92972196 5 
739 PTPN6 PTK2B -30.36253445 -107.3659262 11 
740 VAMP1 VAMP2 -30.33846747 -69.95625593 5 
741 ZNF250 TU3A -30.32094537 -63.78927639 6 
742 FYN YES1 -30.26928892 -111.3274872 9 
743 PAG1 ZAP70 -30.26729977 -67.9525623 7 
744 PTPN11 PTK2 -30.24728526 -121.3937455 12 
745 THBS1 COL1A1 -30.22677991 -97.73549068 8 
746 CD22 VAV1 -30.22331259 -69.70956063 7 
747 BMP7 BMP4 -30.1754454 -66.2271422 5 
748 SNRPB SNRPD1 -30.1754454 -67.28938684 5 
749 SRC YES1 -30.16948538 -117.6526729 9 
750 ABLIM1 RIBC2 -30.14797327 -63.84199498 6 
751 PTPN6 CBL -30.12052074 -114.4451687 11 
752 JAK2 PIK3R1 -30.1170636 -132.7598553 13 
753 DDIT3 ATF4 -30.10441242 -83.51794802 7 
754 STX1A SNAP23 -30.0802505 -113.8608355 8 
755 JAK2 INSR -30.07291882 -113.1983839 10 
756 RELA RXRA -30.06364042 -143.0928839 12 
757 NFKB1 JUN -30.05027524 -131.8268917 12 
758 VAV1 LCP2 -30.02714709 -87.35803829 8 
759 NCOR1 ZBTB16 -30.0252852 -99.81703578 9 
760 PTK2B SHB -30.02217216 -79.34269335 8 
761 LRPAP1 DAB1 -30.0130455 -62.39035372 5 
762 GRB10 SHC1 -29.98785821 -99.95373595 9 
763 USP2 TU3A -29.93313847 -50.42322479 5 
764 AP1G1 AP1G2 -29.92701976 -74.17693941 5 
765 BMPR1B BMPR2 -29.85857895 -96.61389367 7 
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766 ACVR1 SMURF1 -29.85557579 -180.8283706 12 
767 PAG1 PLCG1 -29.82246951 -79.60351768 8 
768 USP7 TRIM37 -29.8203985 -66.23305171 6 
769 FYN NCK1 -29.81354004 -139.4346562 12 
770 PAG1 BCR -29.81052911 -55.89621302 6 
771 EPOR CSF3R -29.80569961 -55.91574806 6 
772 PLSCR1 RBPMS -29.78827891 -148.1500656 11 
773 GTF2A1 TBP -29.76841192 -86.51154003 7 
774 SRC SHC1 -29.76590365 -168.7906788 15 
775 EGFR SHC1 -29.76590365 -162.1615187 15 
776 TSC22D4 EFCBP2 -29.74677946 -81.79213535 7 
777 GDF9 BMP6 -29.7294285 -48.50611559 4 
778 Rhebl1 Rps27a -29.7294285 -36.83099199 4 
779 Rhebl1 Fbxo3 -29.7294285 -36.83099199 4 
780 Rhebl1 Uhmk1 -29.7294285 -36.83099199 4 
781 Rhebl1 Rhod -29.7294285 -36.83099199 4 
782 Arhgef7 Sqstm1 -29.7294285 -35.40988928 4 
783 Arhgef7 Map2k3 -29.7294285 -35.40988928 4 
784 
1200013B22
Rik Uhmk1 -29.7294285 -35.47234916 4 
785 
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Rik Rhod -29.7294285 -35.47234916 4 
786 GDF5 GDF9 -29.72834147 -48.50611559 4 
787 CCL8 CCL11 -29.72834147 -50.19981384 4 
788 CCL8 CCL13 -29.72834147 -50.19981384 4 
789 POP7 RPP14 -29.72834147 -55.74247697 4 
790 POP7 RPP21 -29.72834147 -55.74247697 4 
791 POP4 RPP14 -29.72834147 -55.74247697 4 
792 POP4 RPP21 -29.72834147 -55.74247697 4 
793 Rps27a 
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ik -29.72834147 -35.47234916 4 
794 Rps27a Ilkap -29.72834147 -36.15057069 4 
795 Rps27a Pftk1 -29.72834147 -36.83099199 4 
796 Rps27a Nat5 -29.72834147 -36.83099199 4 
797 Fbxo3 Arhgef6 -29.72834147 -35.59583626 4 
798 Fbxo3 Pftk1 -29.72834147 -36.83099199 4 
799 Fbxo3 Nat5 -29.72834147 -36.83099199 4 
800 Sqstm1 Trim35 -29.72834147 -35.40988928 4 
801 Map2k3 Arhgef6 -29.72834147 -35.59583626 4 
802 Map2k3 Trim35 -29.72834147 -35.40988928 4 
803 Uhmk1 Ilkap -29.72834147 -36.15057069 4 
804 Uhmk1 Pftk1 -29.72834147 -36.83099199 4 
805 Uhmk1 Nat5 -29.72834147 -36.83099199 4 
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806 Rhod Ilkap -29.72834147 -36.15057069 4 
807 Rhod Nkiras1 -29.72834147 -38.15308965 4 
808 GTF2A1 GTF2B -29.69263171 -76.96296024 6 
809 YWHAH YWHAG -29.67995499 -85.85211212 7 
810 DIPA LDOC1 -29.6567833 -138.1661495 11 
811 FN1 HABP2 -29.62070003 -76.79095267 6 
812 HDAC1 SIN3B -29.58543353 -97.96864765 8 
813 C1QR1 FBLN2 -29.57222511 -76.79095267 6 
814 CASP7 CASP9 -29.57222511 -81.62883586 6 
815 PRKCABP SDCBP -29.57222511 -85.31041601 6 
816 CSNK1D CSNK1E -29.57107716 -60.77524715 5 
817 SNRPD2 SNRPD1 -29.56903787 -67.28938684 5 
818 GTF2H1 MNAT1 -29.56814348 -66.48111952 6 
819 NCOA1 NR0B2 -29.56441359 -74.76801853 7 
820 SERPINA5 SERPINB6 -29.55178211 -65.91715059 5 
821 PTK2B SHC1 -29.55122404 -118.3624281 12 
822 JAK2 EGFR -29.5418775 -135.6048075 13 
823 POLR2A BAZ1B -29.53666482 -96.3703725 7 
824 CDH15 CDH2 -29.52780983 -62.62390552 5 
825 CD40 TNFRSF8 -29.52373097 -56.69707335 5 
826 PTK2B PECAM1 -29.48122689 -77.0966084 8 
827 PTK2B BCAR1 -29.4761638 -94.4072495 9 
828 RXRA HNF4A -29.45798692 -104.4827955 8 
829 ITK PLCG2 -29.41780277 -66.48780753 6 
830 PTK2B PLCG1 -29.40724611 -105.7825471 11 
831 RELA SP1 -29.39197455 -130.3367837 12 
832 COL4A1 COL1A2 -29.34175122 -69.93794553 6 
833 RELA MYOD1 -29.34017324 -101.8729666 10 
834 PIK3R1 VAV1 -29.32182843 -124.2346563 12 
835 GHR KIT -29.29760047 -69.09055156 7 
836 TYK2 EPOR -29.29760047 -71.47875929 7 
837 JAK2 KIT -29.27943552 -93.34691818 9 
838 DEF6 ARHGDIA -29.21819531 -42.74755273 4 
839 DSC1 DSC2 -29.21819531 -54.41651876 4 
840 ATP2B4 GUCY1A2 -29.21819531 -43.61261183 4 
841 Rab38 Rhoj -29.21819531 -35.35910128 4 
842 Rhobtb1 Rhoj -29.21819531 -36.83099199 4 
843 B2M LILRB1 -29.20293115 -68.16645686 5 
844 TCF3 ID2 -29.19535356 -78.21011612 6 
845 LSM1 LSM6 -29.18301252 -74.46341483 6 
846 PLCG1 CBL -29.1448595 -112.4999166 11 
847 CDC7 MCM7 -29.12551869 -80.01032244 6 
848 BMPR1B SMAD2 -29.12328583 -175.3069097 12 
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849 LRPAP1 APOE -29.08624926 -62.39035372 5 
850 MAP3K14 TRPC4AP -29.08149027 -54.49440304 5 
851 SRC GRAP2 -29.04477411 -114.6672196 10 
852 RFC4 RFC1 -29.03248885 -62.09133682 5 
853 BMP2 BMP4 -29.02976961 -66.2271422 5 
854 SNRPE SNRPD3 -29.02976961 -65.48657754 5 
855 PPARGC1A NCOA2 -29.01342743 -61.67688606 6 
856 GTF2H1 ERCC3 -29.0101619 -72.97748307 6 
857 KHDRBS1 WAS -29.00092927 -69.56914187 7 
858 YWHAB YWHAG -28.96498241 -85.85211212 7 
859 PLCG1 GRAP2 -28.96453203 -108.8299725 9 
860 PTPN6 EPOR -28.94143404 -92.89211295 9 
861 SYK ITK -28.91871394 -72.61243706 7 
862 NR3C1 JUN -28.9077122 -140.5444232 13 
863 HDAC9 HDAC5 -28.90765905 -67.84873189 6 
864 MCM10 MYST2 -28.89519476 -69.54711026 6 
865 CCL7 CCL11 -28.88049998 -50.19981384 4 
866 CCL7 CCL13 -28.88049998 -50.19981384 4 
867 STRAP Wwp2 -28.88049998 -37.65198224 4 
868 COPB COPB2 -28.8769644 -67.34822734 5 
869 MAP2K1 MAP2K2 -28.8769644 -57.13037623 5 
870 KIAA0408 USP2 -28.8769644 -50.42322479 5 
871 COL4A3 COL1A2 -28.87229329 -69.93794553 6 
872 FN1 MATN2 -28.85352829 -88.12201829 7 
873 EPOR CRKL -28.83777334 -80.09127891 8 
874 PTPN6 RASA1 -28.82583931 -106.2772981 10 
875 TRAF6 MAP3K7 -28.76267001 -108.2190772 8 
876 WWP2 WWP1 -28.75892387 -62.78592424 5 
877 SRC ERBB2 -28.74717966 -109.6039678 11 
878 EGFR PDGFRA -28.74612024 -103.6483368 9 
879 SRC LYN -28.74469116 -155.2766279 13 
880 ERBB2 MUC1 -28.742113 -68.91182163 7 
881 NCOR1 HDAC3 -28.72024739 -110.4278692 9 
882 BRCA1 JUN -28.71278637 -141.3348215 13 
883 GGA3 AP1G1 -28.68105637 -69.74216221 5 
884 KCNJ12 KCNJ4 -28.67561715 -56.39492428 5 
885 BCL2L1 BCL2A1 -28.66261416 -84.67621136 6 
886 FOS ATF3 -28.66261416 -69.65580396 6 
887 HDAC1 DNMT1 -28.64072856 -93.84842714 8 
888 PRKCB1 PRKCD -28.58268394 -93.97435546 7 
889 NSD1 PPARBP -28.57987886 -50.70810029 5 
890 RELA RB1 -28.57115228 -132.4988695 13 
891 PIK3R1 EPOR -28.56861525 -102.2538134 10 
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892 STAT3 PIK3R1 -28.56007532 -132.981611 12 
893 CD40 TNFRSF11A -28.54399 -53.47486974 5 
894 SMARCB1 SMARCC1 -28.54399 -60.1994413 5 
895 JUN TBP -28.53192292 -136.9601126 12 
896 MAPK8 MAPK9 -28.52616406 -86.06256784 7 
897 PLCG1 CRK -28.51318208 -108.3651143 10 
898 GAB2 SHB -28.50342002 -59.79636895 6 
899 ORC1L MCM2 -28.50116267 -77.44608277 6 
900 LSM1 LSM5 -28.49218063 -74.64573639 6 
901 HRAS RRAS2 -28.48684069 -81.74668972 7 
902 VAV1 LCK -28.47502339 -102.7353504 10 
903 CHUK RIPK1 -28.4591813 -77.69048476 7 
904 PLCG1 PLCG2 -28.45595749 -99.3640846 8 
905 SIT1 PTK2B -28.4489583 -57.14192258 6 
906 PML NR3C1 -28.43470265 -108.7244988 11 
907 TNFRSF19 TRIM37 -28.43271869 -53.47486974 5 
908 STAT5A STAT1 -28.43244139 -86.62968762 8 
909 ESR1 VDR -28.40291637 -90.68348975 8 
910 PSMA1 LNX -28.39916854 -77.56049878 7 
911 SRC CRKL -28.39406721 -116.7709607 11 
912 NRIP1 NR0B2 -28.35812221 -68.87628895 6 
913 HSPA1A HSPA8 -28.35095766 -111.364164 8 
914 KHDRBS1 FASLG -28.33195004 -68.99242733 7 
915 SIT1 CBL -28.32126168 -59.36900012 6 
916 BIRC3 BIRC4 -28.30663518 -64.46736764 5 
917 TNPO1 IPO7 -28.30051564 -71.48477226 5 
918 SYK GAB2 -28.29460641 -69.91291521 7 
919 SYK PAG1 -28.29460641 -67.87961111 7 
920 PRKCZ PRKCI -28.2891537 -81.46463484 6 
921 NCOA1 PELP1 -28.28609734 -57.25043877 6 
922 RIBC2 USP2 -28.28281176 -50.42322479 5 
923 VAV1 CRKL -28.24067621 -99.54411743 9 
924 GNB1 GNB5 -28.21979171 -81.58546998 5 
925 ORC1L MCM10 -28.21429848 -76.72650233 6 
926 GHR EGFR -28.20961701 -95.51617822 9 
927 RGS18 RIC8 -28.18898346 -44.28768091 4 
928 RGS16 RGS18 -28.1868091 -44.28768091 4 
929 RGS16 RGS5 -28.1868091 -45.27029429 4 
930 RIC8 RGS5 -28.1868091 -45.27029429 4 
931 RAB11FIP2 RAB11FIP5 -28.1868091 -59.25927319 4 
932 ACTR2 ARPC5 -28.1868091 -57.62736242 4 
933 NRP1 NRP2 -28.1868091 -59.95971967 4 
934 Rasd2 Rhebl1 -28.1868091 -36.83099199 4 
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935 Rasd2 Arhgef7 -28.1868091 -35.40988928 4 
936 Rasd2 
1200013B22R
ik -28.1868091 -35.47234916 4 
937 Rasd2 Arhgef6 -28.1868091 -35.59583626 4 
938 Rasd2 Trim35 -28.1868091 -35.40988928 4 
939 Rasd2 Smad2 -28.1868091 -36.73198694 4 
940 Rasd2 Ilkap -28.1868091 -36.15057069 4 
941 Rasd2 Nkiras1 -28.1868091 -38.15308965 4 
942 Rasd2 Pftk1 -28.1868091 -36.83099199 4 
943 Rasd2 Nat5 -28.1868091 -36.83099199 4 
944 Rasd2 Smad7 -28.1868091 -37.36162024 4 
945 GRB2 PIK3R2 -28.18542496 -102.9243264 9 
946 PTK2 BCAR1 -28.18271888 -102.4010602 9 
947 VAV1 WAS -28.17807724 -81.67199171 8 
948 PAG1 PECAM1 -28.12515664 -58.96763868 6 
949 GHR BCR -28.12189067 -57.57909023 6 
950 TYK2 IL4R -28.12189067 -68.83726301 6 
951 FLJ32855 TU3A -28.12189067 -60.3720014 6 
952 CD22 EPOR -28.11973949 -55.28788369 6 
953 SAA1 HABP2 -28.11971896 -50.17449604 4 
954 ASIP POMC -28.11971896 -63.55428844 4 
955 POP1 POP7 -28.11971896 -55.74247697 4 
956 POP1 POP4 -28.11971896 -55.74247697 4 
957 Rab38 Rps27a -28.11971896 -35.35910128 4 
958 Rab38 Fbxo3 -28.11971896 -35.59583626 4 
959 Rab38 Sqstm1 -28.11971896 -36.08811081 4 
960 Rab38 Uhmk1 -28.11971896 -35.35910128 4 
961 Rab38 Rhod -28.11971896 -35.35910128 4 
962 Rhobtb1 Sqstm1 -28.11971896 -38.00368784 4 
963 Rhobtb1 Map2k3 -28.11971896 -36.03952258 4 
964 Rhobtb1 Rhod -28.11971896 -36.83099199 4 
965 CCL8 CCL14 -28.11917541 -50.19981384 4 
966 MAP2K2 KSR2 -28.11917541 -44.02281861 4 
967 SCNN1G SCNN1A -28.11917541 -52.72839556 4 
968 TAF1A TAF1B -28.11917541 -46.92642106 4 
969 TAF1C TAF1B -28.11917541 -46.92642106 4 
970 CRIPT ATP2B4 -28.11917541 -43.61261183 4 
971 CRIPT GUCY1A2 -28.11917541 -43.61261183 4 
972 CDC45L CCDC5 -28.11917541 -47.13266257 4 
973 SFRS2IP SFRS11 -28.11917541 -48.7106621 4 
974 AQP1 FLJ22746 -28.11917541 -39.12516735 4 
975 Rps27a Stat1 -28.11917541 -35.47234916 4 
976 Fbxo3 Rhoj -28.11917541 -36.83099199 4 
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977 Sqstm1 Rhoj -28.11917541 -37.32326654 4 
978 Sqstm1 Smad3 -28.11917541 -35.40988928 4 
979 Sqstm1 Rras2 -28.11917541 -36.87958022 4 
980 Map2k3 Rhoj -28.11917541 -35.35910128 4 
981 Map2k3 Smad3 -28.11917541 -35.40988928 4 
982 Uhmk1 Stat1 -28.11917541 -35.47234916 4 
983 Rhod Rras2 -28.11917541 -38.6453642 4 
984 Rhod Stat1 -28.11917541 -36.79444682 4 
985 EPOR PRLR -28.10667203 -71.25452147 6 
986 SMN1 LSM6 -28.10667203 -74.79081157 6 
987 VAMP8 VAMP2 -28.10596483 -61.57591392 5 
988 SNX6 SNX4 -28.10188542 -57.44171401 5 
989 MAPK8IP3 DUSP16 -28.10188542 -63.3004028 5 
990 MAP3K14 TNFRSF11A -28.10188542 -52.45233975 5 
991 CFLAR DEDD -28.10188542 -60.34274537 5 
992 PROC F10 -28.06727287 -68.03132419 5 
993 SNRPB SNRPD2 -28.06727287 -67.28938684 5 
994 GRB2 SHB -28.03828855 -107.7701219 10 
995 SPTAN1 SPTA1 -28.01033347 -68.63134539 5 
996 EXOC8 RALA -28.00370146 -91.69729533 6 
997 B2M LILRB2 -27.95180083 -68.16645686 5 
998 NCOA1 NR3C1 -27.94520126 -120.6194393 11 
999 RAPGEF1 CRKL -27.94002377 -61.59795291 6 
1000 RIPK1 MAP3K14 -27.93834498 -61.73017949 6 
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Table S2 Predictions of 466 KEGG pathways for 274 proteins and 123 GO annotations 
for 114 proteins. The 2nd column is the predicted KEGG and GO IDs for proteins in the 1st 
column, with 3rd column as corresponding KEGG pathway names and GO terms. Ratio is the 
number of significant partners with the assigned annotation(s) divided by the total number of 
significant partners. P values were first calculated by Fisher‘s exact test and then adjusted by 
―BH‖ method [81]. Table S2 was partially reproduced from REF. 76. 
 
Protein KEGG ID KEGG Pathway Name Ratio P value 
DNASE1 hsa04810 Regulation of actin cytoskeleton 2/2 0.00302 
DLG4 hsa04080; 
hsa04530; 
hsa04720 
Neuroactive ligand-receptor interaction;  
Tight junction; Long-term potentiation 
2/11 0.144; 
0.0366; 
0.0129 
GRIN2B hsa04020 Calcium signaling pathway 3/6 0.00169 
PML hsa05220 Chronic myeloid leukemia 4/30 0.00204 
CREBBP hsa04010; 
hsa04620; 
hsa04660; 
hsa04662 
MAPK signaling pathway;  
Toll-like receptor signaling pathway;  
T cell receptor signaling pathway;  
B cell receptor signaling pathway 
3/12 0.0276; 
0.00278; 
0.00321; 
0.00144 
NCOR1 hsa04330 Notch signaling pathway 2/9 0.00458 
NCOR2 hsa04110; 
hsa05220 
Cell cycle;  
Chronic myeloid leukemia 
3/14 0.00565; 
0.00208 
RARA hsa03320; 
hsa04080 
PPAR signaling pathway;  
Neuroactive ligand-receptor interaction 
3/9 0.000607; 
0.0165 
BRCA1 hsa04110; 
hsa05212; 
hsa05220 
Cell cycle; Pancreatic cancer; 
 Chronic myeloid leukemia 
4/22 0.00282; 
0.000722; 
0.000821 
TGFBR3 hsa04010; 
hsa04060; 
hsa04350; 
hsa05210; 
hsa05212; 
hsa05220 
MAPK signaling pathway;  
Cytokine-cytokine receptor interaction; 
TGF-beta signaling pathway; 
 Colorectal cancer; Pancreatic cancer;  
Chronic myeloid leukemia 
2/6 0.0414; 
0.0422; 
0.00607; 
0.00583; 
0.00442; 
0.0047 
GDF9 hsa04350 TGF-beta signaling pathway 5/5 3.91E-08 
IGSF1 hsa04060; 
hsa04350 
Cytokine-cytokine receptor interaction; 
TGF-beta signaling pathway 
6/6 3.46e-07; 
1.29e-09 
NCOA1 hsa04920 Adipocytokine signaling pathway 5/38 0.000551 
NR3C1 hsa04620; 
hsa04920 
Toll-like receptor signaling pathway; 
Adipocytokine signaling pathway 
4/22 0.00181; 
6e-04 
STATIP1 hsa04060; 
hsa04630 
Cytokine-cytokine receptor interaction; 
Jak-STAT signaling pathway 
2/3 0.0109; 
0.00422 
MET hsa04810 Regulation of actin cytoskeleton 3/6 0.00253 
KHDRBS1 hsa04650; 
hsa04660 
Natural killer cell mediated cytotoxicity;  
T cell receptor signaling pathway 
5/18 0.000396; 
0.000144 
AR hsa04110; Cell cycle;  3/19 0.012; 
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hsa05212; 
hsa05220 
Pancreatic cancer;  
Chronic myeloid leukemia 
0.00392; 
0.00426 
PTPN11 hsa04510 Focal adhesion 16/50 3.81E-09 
RET hsa04510 Focal adhesion 7/15 6.87E-06 
JUN hsa05220 Chronic myeloid leukemia 7/35 7.60E-06 
TRAF3 hsa04010 MAPK signaling pathway 2/4 0.019 
LRPAP1 hsa05010 Alzheimer's disease 2/4 0.00865 
APH1B hsa04330; 
hsa05010 
Notch signaling pathway;  
Alzheimer's disease 
2/2 0.000308; 
0.0021 
CD19 hsa04650 Natural killer cell mediated cytotoxicity 5/10 2.40E-05 
CD22 hsa04650; 
hsa04660 
Natural killer cell mediated cytotoxicity;  
T cell receptor signaling pathway 
8/23 1.43e-06; 
2.97e-07 
ELA2 hsa04080 Neuroactive ligand-receptor interaction 2/4 0.0225 
CD3E hsa04630; 
hsa04910; 
hsa05220 
Jak-STAT signaling pathway; 
 Insulin signaling pathway; 
Chronic myeloid leukemia 
2/6 0.0157; 
0.0128; 
0.0047 
GNB2L1 hsa04630; 
hsa04650; 
hsa04670; 
hsa04910; 
hsa04920; 
hsa04930; 
hsa05220 
Jak-STAT signaling pathway;  
Natural killer cell mediated cytotoxicity; 
Leukocyte transendothelial migration;  
Insulin signaling pathway;  
Adipocytokine signaling pathway;  
Type II diabetes mellitus;  
Chronic myeloid leukemia 
2/3 0.00422; 
0.00362; 
0.00281; 
0.00351; 
0.00121; 
0.000711; 
0.0014 
TRAF2 hsa04620 Toll-like receptor signaling pathway 4/17 0.000848 
TRAF1 hsa04010; 
hsa04210 
MAPK signaling pathway;  
Apoptosis 
4/10 0.00253; 
9.35e-05 
CSK hsa04650 Natural killer cell mediated cytotoxicity 10/15 1.32E-10 
TNK2 hsa04630; 
hsa04810; 
hsa04910 
Jak-STAT signaling pathway;  
Regulation of actin cytoskeleton;  
Insulin signaling pathway 
2/3 0.00422; 
0.00713; 
0.00351 
KIT hsa04630 Jak-STAT signaling pathway 11/38 2.82E-07 
SIT1 hsa04670 Leukocyte transendothelial migration 5/8 3.53E-06 
BLNK hsa04650; 
hsa04660; 
hsa04664 
Natural killer cell mediated cytotoxicity;  
T cell receptor signaling pathway;  
Fc epsilon RI signaling pathway 
7/15 8.33e-07; 
2.32e-07; 
3.91e-08 
GAB1 hsa04510 Focal adhesion 11/27 7.15E-08 
IRS2 hsa04630 Jak-STAT signaling pathway 9/27 8.70E-07 
GAB2 hsa04650 Natural killer cell mediated cytotoxicity 11/34 3.99E-08 
IRS4 hsa04060 Cytokine-cytokine receptor interaction 4/7 0.000751 
PTPN12 hsa04510 Focal adhesion 9/15 3.25E-08 
ADAM15 hsa04670 Leukocyte transendothelial migration 3/10 0.00253 
MUC1 hsa04510 Focal adhesion 5/9 6.00E-05 
PTPRC hsa04650 Natural killer cell mediated cytotoxicity 7/15 8.33E-07 
TEK hsa04060 Cytokine-cytokine receptor interaction 4/5 0.000177 
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CD2AP hsa04670 Leukocyte transendothelial migration 3/10 0.00253 
DNM1 hsa04810 Regulation of actin cytoskeleton 2/3 0.00713 
ABL1 hsa04510 Focal adhesion 5/9 6.00E-05 
PAG1 hsa04660 T cell receptor signaling pathway 13/45 8.51E-10 
CD28 hsa04640 Hematopoietic cell lineage 4/12 0.000177 
MAPK14 hsa04510; 
hsa04910; 
hsa04930; 
hsa05210; 
hsa05212 
Focal adhesion;  
Insulin signaling pathway;  
Type II diabetes mellitus;  
Colorectal cancer;  
Pancreatic cancer 
3/3 0.000231; 
9.48e-05; 
6.83e-06; 
2.8e-05; 
1.96e-05 
RAPGEF1 hsa04670; 
hsa04810 
Leukocyte transendothelial migration; 
Regulation of actin cytoskeleton 
5/10 1.28e-05; 
0.000137 
BCL2A1 hsa01510; 
hsa04210; 
hsa05030 
Neurodegenerative Diseases;  
Apoptosis;  
Amyotrophic lateral sclerosis (ALS) 
2/3 NA; 
0.0018; 
NA 
GAB3 hsa04060 Cytokine-cytokine receptor interaction 5/21 0.00696 
CSF1R hsa04630; 
hsa04670 
Jak-STAT signaling pathway;  
Leukocyte transendothelial migration 
4/17 0.00278;0.0
0132 
GRB7 hsa04650; 
hsa05214 
Natural killer cell mediated cytotoxicity;  
Glioma 
6/11 1.98e-06; 
5.2e-08 
TUB hsa04510 Focal adhesion 3/8 0.00459 
FRS2 hsa04650; 
hsa05214 
Natural killer cell mediated cytotoxicity;  
Glioma 
2/4 0.00627; 
0.00188 
ITK hsa04664 Fc epsilon RI signaling pathway 8/13 4.73E-10 
MST1R hsa04510; 
hsa04810 
Focal adhesion;  
Regulation of actin cytoskeleton 
4/10 0.00108; 
0.00131 
PTK2B hsa04630 Jak-STAT signaling pathway 21/68 1.39E-12 
EPHA2 hsa04920 Adipocytokine signaling pathway 3/6 0.000185 
SCAP1 hsa04650; 
hsa04670 
Natural killer cell mediated cytotoxicity; 
Leukocyte transendothelial migration 
4/14 0.00118; 
0.000719 
CALD1 hsa04080 Neuroactive ligand-receptor interaction 2/15 0.233 
CBLB hsa04650 Natural killer cell mediated cytotoxicity 8/19 3.44E-07 
SYNJ1 hsa04810 Regulation of actin cytoskeleton 2/3 0.00713 
SH3KBP1 hsa04010; 
hsa04510; 
hsa04910; 
hsa05220 
MAPK signaling pathway;  
Focal adhesion;  
Insulin signaling pathway;  
Chronic myeloid leukemia 
2/4 0.019; 
0.0114; 
0.00608; 
0.00238 
INPP5D hsa04630 Jak-STAT signaling pathway 6/11 3.23E-06 
RASA1 hsa04510 Focal adhesion 11/22 7.50E-09 
SHB hsa04650; 
hsa04660 
Natural killer cell mediated cytotoxicity;  
T cell receptor signaling pathway 
8/25 2.84e-06; 
4.91e-07 
BCR hsa04630 Jak-STAT signaling pathway 9/17 1.62E-08 
SYN1 hsa04020; 
hsa04510; 
Calcium signaling pathway;  
Focal adhesion;  
2/6 0.0199; 
0.0244; 
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hsa04670; 
hsa04810 
Leukocyte transendothelial migration; 
Regulation of actin cytoskeleton 
0.0101; 
0.0275 
BCL3 hsa04620; 
hsa05120 
Toll-like receptor signaling pathway;  
Epithelial cell signaling in Helicobacter pylori 
infection 
2/8 0.0128; 
0.00677 
GIT2 hsa04810 Regulation of actin cytoskeleton 3/3 0.000276 
HLA-F hsa04650 Natural killer cell mediated cytotoxicity 4/4 5.10E-06 
CTLA4 hsa04670 Leukocyte transendothelial migration 2/7 0.0132 
SOSTDC1 hsa04350 TGF-beta signaling pathway 3/3 2.93E-05 
PCTK1 hsa04010 MAPK signaling pathway 2/6 0.0414 
REM1 hsa04010; 
hsa04510; 
hsa04910; 
hsa05210; 
hsa05212; 
hsa05218; 
hsa05220 
MAPK signaling pathway; 
 Focal adhesion;  
Insulin signaling pathway;  
Colorectal cancer;  
Pancreatic cancer;  
Melanoma;  
Chronic myeloid leukemia 
3/11 0.0219; 
0.0107; 
0.00438; 
0.00153; 
0.00109; 
0.00107; 
0.00119 
E2F4 hsa05220 Chronic myeloid leukemia 3/10 0.000945 
RBBP4 hsa05220 Chronic myeloid leukemia 5/17 2.62E-05 
ERBB2IP hsa05217 Basal cell carcinoma 2/4 0.00149 
KRT18 hsa04370; 
hsa04510 
VEGF signaling pathway;  
Focal adhesion 
2/7 0.00627; 
0.0326 
CTNNB1 hsa04514 Cell adhesion molecules (CAMs) 2/4 0.00581 
RICS hsa04510 Focal adhesion 8/15 4.32E-07 
CTNNA1 hsa05216 Thyroid cancer 2/2 0.000147 
GRIK2 hsa00230 Purine metabolism 2/7 0.0199 
BAD hsa04010 MAPK signaling pathway 2/12 0.143 
MYF6 hsa04080 Neuroactive ligand-receptor interaction 2/18 0.299 
ASCL2 hsa04080 Neuroactive ligand-receptor interaction 2/18 0.299 
PPEF2 hsa04080 Neuroactive ligand-receptor interaction 2/18 0.299 
KCNQ5 hsa04080 Neuroactive ligand-receptor interaction 2/15 0.233 
PPEF1 hsa04080 Neuroactive ligand-receptor interaction 2/18 0.299 
ESR1 hsa04110 Cell cycle 4/21 0.00249 
GRM7 hsa04310 Wnt signaling pathway 2/11 0.0451 
EMP3 hsa04080 Neuroactive ligand-receptor interaction 2/17 0.279 
CALM3 hsa04350 TGF-beta signaling pathway 2/4 0.00295 
STX1A hsa04130 SNARE interactions in vesicular transport 5/6 6.01E-09 
ITGB1 hsa04640 Hematopoietic cell lineage 4/6 1.07E-05 
SPIB hsa04010 MAPK signaling pathway 2/2 0.00436 
FOS hsa04310 Wnt signaling pathway 4/19 0.00367 
PKP2 hsa01430 Cell Communication 3/5 NA 
PECAM1 hsa04510; 
hsa04640 
Focal adhesion;  
Hematopoietic cell lineage 
4/26 0.0223; 
0.00207 
SERPINB13 hsa04610 Complement and coagulation cascades 2/2 0.000565 
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PCAF hsa01510; 
hsa04110; 
hsa04310; 
hsa04350; 
hsa04520; 
hsa04630; 
hsa04720; 
hsa04916; 
hsa05040 
Neurodegenerative Diseases;  
Cell cycle;  
Wnt signaling pathway;  
TGF-beta signaling pathway;  
Adherens junction;  
Jak-STAT signaling pathway;  
Long-term potentiation;  
Melanogenesis;  
Huntington's disease 
2/2 NA; 
0.00122; 
0.00178; 
0.000776; 
0.000643; 
0.0018; 
0.000591; 
0.00101; 
NA 
MYC hsa04110 Cell cycle 2/5 0.00712 
CEBPB hsa04620 Toll-like receptor signaling pathway 3/10 0.00178 
CEBPG hsa04010 MAPK signaling pathway 4/9 0.00178 
CKS1B hsa04110 Cell cycle 2/2 0.00122 
BIRC5 hsa04210; 
hsa04510 
Apoptosis;  
Focal adhesion 
3/5 0.000208;0.
00132 
LYN hsa04650 Natural killer cell mediated cytotoxicity 12/22 4.55E-11 
MCM10 hsa04110 Cell cycle 12/26 5.61E-11 
AKAP8 hsa04110; 
hsa05212; 
hsa05214; 
hsa05218; 
hsa05220 
Cell cycle;  
Pancreatic cancer;  
Glioma;  
Melanoma; 
 Chronic myeloid leukemia 
2/3 0.00278; 
0.00132; 
0.00116; 
0.00131; 
0.0014 
CDC25A hsa04010 MAPK signaling pathway 2/3 0.0107 
CDC42 hsa04310 Wnt signaling pathway 3/5 0.00071 
KTN1 hsa04810 Regulation of actin cytoskeleton 2/4 0.0128 
ACTR3 hsa04810 Regulation of actin cytoskeleton 2/3 0.00713 
RAC2 hsa05120 Epithelial cell signaling in Helicobacter pylori 
infection 
2/2 0.00056 
SUV39H1 hsa00271; 
hsa04110 
Methionine metabolism;  
Cell cycle 
2/13 NA; 
0.0398 
PHB hsa04110 Cell cycle 2/7 0.0131 
RBBP8 hsa04110 Cell cycle 2/3 0.00278 
BAK1 hsa04210 Apoptosis 3/7 0.000565 
PXN hsa04650 Natural killer cell mediated cytotoxicity 6/16 2.12E-05 
COL4A3 hsa01430; 
hsa04510; 
hsa04512 
Cell Communication;  
Focal adhesion;  
ECM-receptor interaction 
6/7 NA; 
3.46e-07; 
5.74e-09 
COL7A1 hsa04350 TGF-beta signaling pathway 2/3 0.00177 
SPARC hsa01430; 
hsa04350; 
hsa04510; 
hsa04512; 
hsa04810 
Cell Communication;  
TGF-beta signaling pathway;  
Focal adhesion;  
ECM-receptor interaction;  
Regulation of actin cytoskeleton 
2/5 NA; 
0.00436; 
0.0174; 
0.0042; 
0.0194 
CD36 hsa04670 Leukocyte transendothelial migration 3/5 0.000432 
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COL4A5 hsa01430; 
hsa04510; 
hsa04512 
Cell Communication;  
Focal adhesion;  
ECM-receptor interaction 
6/7 NA; 
3.46e-07; 
5.74e-09 
CDK3 hsa04110 Cell cycle 2/3 0.00278 
DSP hsa01430 Cell Communication 2/2 NA 
JUND hsa04912 GnRH signaling pathway 2/4 0.0037 
ERCC3 hsa03022 Basal transcription factors 2/5 0.0013 
SUMO1 hsa04010; 
hsa04110; 
hsa05220 
MAPK signaling pathway;  
Cell cycle;  
Chronic myeloid leukemia 
2/6 0.0414; 
0.00999; 
0.0047 
GNAZ hsa04916 Melanogenesis 3/3 4.59E-05 
ENG hsa04060; 
hsa04350 
Cytokine-cytokine receptor interaction;  
TGF-beta signaling pathway 
3/7 0.00683; 
0.00056 
GRB10 hsa04650; 
hsa04910 
Natural killer cell mediated cytotoxicity;  
Insulin signaling pathway 
7/11 7.97e-08; 
7.15e-08 
RGS16 hsa04080 Neuroactive ligand-receptor interaction 5/14 0.00191 
TRIP4 hsa04920 Adipocytokine signaling pathway 4/22 6.00E-04 
POU2F1 hsa04620; 
hsa05120 
Toll-like receptor signaling pathway; 
Epithelial cell signaling in Helicobacter pylori 
infection 
3/14 0.00399; 
0.0017 
PELP1 hsa04110; 
hsa04310; 
hsa04510; 
hsa05210 
Cell cycle;  
Wnt signaling pathway;  
Focal adhesion;  
Colorectal cancer 
2/8 0.0167; 
0.0255; 
0.0414; 
0.00975 
MNAT1 hsa03022 Basal transcription factors 2/4 0.000882 
NRIP1 hsa04010; 
hsa04920; 
hsa05220 
MAPK signaling pathway;  
Adipocytokine signaling pathway;  
Chronic myeloid leukemia 
2/11 0.123; 
0.0114; 
0.0137 
BTK hsa04660 T cell receptor signaling pathway 3/3 5.17E-05 
CASP8AP2 hsa04210 Apoptosis 4/4 9.74E-07 
GRAP2 hsa04664 Fc epsilon RI signaling pathway 5/7 2.97E-07 
FOSL1 hsa04010 MAPK signaling pathway 2/5 0.0293 
TRPV4 hsa04670 Leukocyte transendothelial migration 3/10 0.00253 
NEDD9 hsa04510 Focal adhesion 7/13 2.27E-06 
CD2 hsa04660 T cell receptor signaling pathway 5/6 3.46E-07 
CASP7 hsa05210 Colorectal cancer 2/3 0.0017 
INSR hsa04630 Jak-STAT signaling pathway 8/17 2.82E-07 
HCK hsa04650; 
hsa04660; 
hsa04664 
Natural killer cell mediated cytotoxicity;  
T cell receptor signaling pathway;  
Fc epsilon RI signaling pathway 
3/4 0.000302; 
0.000163; 
7.19e-05 
RAP1A hsa04530; 
hsa04810 
Tight junction;  
Regulation of actin cytoskeleton 
3/5 0.00056; 
0.00152 
YES1 hsa04510; 
hsa04664 
Focal adhesion;  
Fc epsilon RI signaling pathway 
3/4 0.00068; 
7.19e-05 
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NGB hsa04080 Neuroactive ligand-receptor interaction 2/12 0.165 
RGS14 hsa04080 Neuroactive ligand-receptor interaction 2/9 0.103 
RIC8 hsa04080 Neuroactive ligand-receptor interaction 6/15 0.000497 
UNC119 hsa04514 Cell adhesion molecules (CAMs) 2/3 0.00337 
LILRB2 hsa04612 Antigen processing and presentation 2/3 0.0018 
RHOA hsa04010; 
hsa04370; 
hsa05120; 
hsa05212 
MAPK signaling pathway;  
VEGF signaling pathway;  
Epithelial cell signaling in Helicobacter pylori 
infection; Pancreatic cancer 
2/4 0.019; 
0.00238; 
0.00204; 
0.00222 
IGF1R hsa04630 Jak-STAT signaling pathway 7/12 2.97E-07 
SHC1 hsa04630 Jak-STAT signaling pathway 15/50 1.29E-09 
SOCS2 hsa04920 Adipocytokine signaling pathway 3/3 1.66E-05 
SOCS3 hsa04650 Natural killer cell mediated cytotoxicity 6/10 9.74E-07 
PRKCD hsa04010; 
hsa04020; 
hsa04070; 
hsa04310; 
hsa04370; 
hsa04510; 
hsa04540; 
hsa04650; 
hsa04670; 
hsa04720; 
hsa04730; 
hsa04916; 
hsa05214 
MAPK signaling pathway;  
Calcium signaling pathway; 
Phosphatidylinositol signaling system;  
Wnt signaling pathway;  
VEGF signaling pathway;  
Focal adhesion;  
Gap junction;  
Natural killer cell mediated cytotoxicity; 
Leukocyte transendothelial migration; 
Long-term potentiation;  
Long-term depression;  
Melanogenesis;  
Glioma 
3/3 0.000518; 
0.000177; 
2.15e-05; 
0.000121; 
2.12e-05; 
0.000231; 
3.3e-05; 
9.95e-05; 
6.5e-05; 
1.96e-05; 
1.94e-05; 
4.59e-05; 
1.54e-05 
SERPINB6 hsa04610 Complement and coagulation cascades 2/2 0.000565 
BIK hsa04210 Apoptosis 3/5 0.000208 
BCL2L11 hsa01510; 
hsa04210; 
hsa05030; 
hsa05210 
Neurodegenerative Diseases;  
Apoptosis;  
Amyotrophic lateral sclerosis (ALS);  
Colorectal cancer 
2/4 NA; 
0.00306; 
NA; 
0.00285 
PMAIP1 hsa04210 Apoptosis 3/7 0.000565 
TRAF5 hsa04010 MAPK signaling pathway 2/4 0.019 
CD5 hsa04660 T cell receptor signaling pathway 6/10 2.97E-07 
ASIP hsa04080; 
hsa04920 
Neuroactive ligand-receptor interaction; 
Adipocytokine signaling pathway 
2/2 0.0051; 
0.00056 
MAP1A hsa04020 Calcium signaling pathway 2/7 0.0265 
CCBP2 hsa04060 Cytokine-cytokine receptor interaction 4/6 0.000432 
JUNB hsa04010 MAPK signaling pathway 3/4 0.00132 
SP1 hsa05220 Chronic myeloid leukemia 4/15 0.000231 
SKI hsa04110; 
hsa04350 
Cell cycle; TGF-beta signaling pathway 3/3 6.45e-05; 
2.93e-05 
MAP3K8 hsa04210; Apoptosis;  2/2 0.000806; 
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hsa04620; 
hsa04662; 
hsa04920; 
hsa05120; 
hsa05212; 
hsa05220 
Toll-like receptor signaling pathway; B cell 
receptor signaling pathway; Adipocytokine 
signaling pathway;  
Epithelial cell signaling in Helicobacter pylori 
infection; Pancreatic cancer;  
Chronic myeloid leukemia 
0.000974; 
0.000613; 
0.00056; 
0.00056; 
0.000591; 
0.000613 
BRAF hsa04110; 
hsa04370 
Cell cycle; VEGF signaling pathway 2/7 0.0131; 
0.00627 
RAP2A hsa04010 MAPK signaling pathway 4/5 0.000171 
BATF hsa04010 MAPK signaling pathway 3/10 0.0172 
TOB1 hsa05217 Basal cell carcinoma 2/5 0.00219 
RASIP1 hsa04670; 
hsa05210; 
hsa05212 
Leukocyte transendothelial migration; 
Colorectal cancer; Pancreatic cancer 
2/6 0.0101; 
0.00583; 
0.00442 
CRKL hsa04650 Natural killer cell mediated cytotoxicity 14/43 8.51E-10 
SLA hsa04650 Natural killer cell mediated cytotoxicity 4/5 1.98E-05 
UBE2L3 hsa04120 Ubiquitin mediated proteolysis 2/5 0.00918 
HDAC3 hsa04330 Notch signaling pathway 3/16 0.00108 
KCNA4 hsa04020 Calcium signaling pathway 3/8 0.00353 
KSR2 hsa04010 MAPK signaling pathway 4/5 0.000171 
PRKCG hsa04664; 
hsa04912 
Fc epsilon RI signaling pathway;  
GnRH signaling pathway 
3/3 2.26e-05; 
4.43e-05 
RHOG hsa04360; 
hsa04510; 
hsa04520; 
hsa04670; 
hsa04810 
Axon guidance;  
Focal adhesion;  
Adherens junction;  
Leukocyte transendothelial migration; 
Regulation of actin cytoskeleton 
3/3 7.91e-05; 
0.000231; 
2.2e-05; 
6.5e-05; 
0.000276 
NAPA hsa04130 SNARE interactions in vesicular transport 4/6 6.16E-07 
ERBB3 hsa04320; 
hsa04510 
Dorso-ventral axis formation;  
Focal adhesion 
3/3 NA; 
0.000231 
STRAP hsa04350 TGF-beta signaling pathway 2/5 0.00436 
TNFAIP3 hsa04010 MAPK signaling pathway 5/15 0.0018 
ZNF8 hsa05217 Basal cell carcinoma 2/5 0.00219 
ALS2CR2 hsa04010; 
hsa04620 
MAPK signaling pathway; Toll-like receptor 
signaling pathway 
2/2 0.00436; 
0.000974 
CASP9 hsa01510; 
hsa05010; 
hsa05050 
Neurodegenerative Diseases;  
Alzheimer's disease; 
Dentatorubropallidoluysian atrophy (DRPLA) 
2/3 NA; 
0.00483; 
NA 
DIABLO hsa04210 Apoptosis 3/4 9.95E-05 
KCNJ12 hsa04020 Calcium signaling pathway 5/17 0.000699 
MAP3K14 hsa04060 Cytokine-cytokine receptor interaction 6/17 0.000608 
TRPC4AP hsa04210 Apoptosis 8/13 8.51E-10 
TANK hsa04060 Cytokine-cytokine receptor interaction 5/9 0.000208 
SH3BP5 hsa04010 MAPK signaling pathway 2/3 0.0107 
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SIN3A hsa04110; 
hsa04330; 
hsa05220 
Cell cycle;  
Notch signaling pathway;  
Chronic myeloid leukemia 
3/16 0.00782; 
0.00108; 
0.00285 
E2F2 hsa04110; 
hsa05212; 
hsa05214; 
hsa05218; 
hsa05220 
Cell cycle;  
Pancreatic cancer;  
Glioma;  
Melanoma;  
Chronic myeloid leukemia 
2/3 0.00278; 
0.00132; 
0.00116; 
0.00131; 
0.0014 
PLCG2 hsa04660 T cell receptor signaling pathway 6/8 5.76E-08 
MCL1 hsa01510; 
hsa04210; 
hsa05030 
Neurodegenerative Diseases;  
Apoptosis;  
Amyotrophic lateral sclerosis (ALS) 
2/3 NA; 
0.0018; 
NA 
AHR hsa03320; 
hsa04010; 
hsa04620; 
hsa04660; 
hsa04662; 
hsa04920; 
hsa05210 
PPAR signaling pathway;  
MAPK signaling pathway;  
Toll-like receptor signaling pathway; 
 T cell receptor signaling pathway;  
B cell receptor signaling pathway; 
Adipocytokine signaling pathway;  
Colorectal cancer 
2/13 0.0162; 
0.161; 
0.0303; 
0.034; 
0.0185; 
0.0154; 
0.0226 
HNF4A hsa04080 Neuroactive ligand-receptor interaction 2/7 0.0657 
PPARBP hsa04920 Adipocytokine signaling pathway 3/23 0.00519 
DUSP22 hsa04010 MAPK signaling pathway 2/3 0.0107 
ID2 hsa04020; 
hsa04070; 
hsa04720; 
hsa04740; 
hsa04910; 
hsa04912; 
hsa04916; 
hsa05040; 
hsa05214 
Calcium signaling pathway; 
Phosphatidylinositol signaling system; 
Long-term potentiation;  
Olfactory transduction;  
Insulin signaling pathway;  
GnRH signaling pathway;  
Melanogenesis;  
Huntington's disease;  
Glioma 
2/6 0.0199; 
0.00481; 
0.00442; 
0.0769; 
0.0128; 
0.00766; 
0.00791; 
NA; 
0.00384 
PPARD hsa04920 Adipocytokine signaling pathway 2/5 0.00295 
SH3BP2 hsa04660 T cell receptor signaling pathway 7/12 3.99E-08 
KCNJ4 hsa04020 Calcium signaling pathway 3/10 0.00627 
BIRC7 hsa04210; 
hsa04510 
Apoptosis;  
Focal adhesion 
3/4 9.95e-05; 
0.00068 
SNIP1 hsa05217 Basal cell carcinoma 2/3 0.000896 
CRIPT hsa04020 Calcium signaling pathway 4/14 0.00224 
SEMA4C hsa00230 Purine metabolism 2/7 0.0199 
GDA hsa04020 Calcium signaling pathway 3/8 0.00353 
KCNJ10 hsa04020; 
hsa04080; 
hsa04720 
Calcium signaling pathway;  
Neuroactive ligand-receptor interaction; 
Long-term potentiation 
3/5 0.00103; 
0.00322; 
0.00013 
PGF hsa04060 Cytokine-cytokine receptor interaction 2/3 0.0109 
 - 121 - 
 
SIN3B hsa04330; 
hsa05220 
Notch signaling pathway;  
Chronic myeloid leukemia 
3/4 2.14e-05; 
6.57e-05 
ZNFN1A1 hsa04330; 
hsa05220 
Notch signaling pathway;  
Chronic myeloid leukemia 
3/8 0.000185; 
0.00056 
THRB hsa03320 PPAR signaling pathway 3/8 0.000476 
USP7 hsa04060 Cytokine-cytokine receptor interaction 11/15 9.44E-10 
TRIM37 hsa04060 Cytokine-cytokine receptor interaction 5/13 0.00109 
MAP4K1 hsa04910 Insulin signaling pathway 3/5 0.000588 
DEDD hsa04210 Apoptosis 4/5 4.22E-06 
CDC5L hsa04110 Cell cycle 4/5 1.09E-05 
KIF1C hsa04010 MAPK signaling pathway 2/7 0.0553 
DAB1 hsa05010 Alzheimer's disease 2/4 0.00865 
RIPK2 hsa04210 Apoptosis 4/12 0.000182 
ACTR2 hsa04810 Regulation of actin cytoskeleton 5/6 6.83E-06 
TP73 hsa04110; 
hsa05212; 
hsa05214; 
hsa05218; 
hsa05220 
Cell cycle;  
Pancreatic cancer;  
Glioma;  
Melanoma;  
Chronic myeloid leukemia 
2/2 0.00122; 
0.000591; 
0.000542; 
0.000588; 
0.000613 
DMTF1 hsa04110; 
hsa05220 
Cell cycle; Chronic myeloid leukemia 3/5 0.000425;0.
000144 
DIPA hsa01430 Cell Communication 2/19 NA 
USHBP1 hsa01430 Cell Communication 3/4 NA 
CCNH hsa00500; 
hsa00790 
Starch and sucrose metabolism; 
 Folate biosynthesis 
2/4 0.00138; 
0.000147 
HOOK2 hsa01430 Cell Communication 2/9 NA 
ESR2 hsa03320; 
hsa05216 
PPAR signaling pathway;  
Thyroid cancer 
2/8 0.00691; 
0.00186 
IGF2 hsa04150 mTOR signaling pathway 2/3 0.000829 
ATF3 hsa04010 MAPK signaling pathway 3/8 0.00955 
FOSL2 hsa04010 MAPK signaling pathway 3/8 0.00955 
UCP2 hsa04010; 
hsa04510; 
hsa04910; 
hsa05210; 
hsa05212; 
hsa05218; 
hsa05220 
MAPK signaling pathway;  
Focal adhesion;  
Insulin signaling pathway; 
 Colorectal cancer;  
Pancreatic cancer;  
Melanoma;  
Chronic myeloid leukemia 
2/5 0.0293; 
0.0174; 
0.00925; 
0.00422; 
0.00327; 
0.00322; 
0.0035 
UCP3 hsa04010; 
hsa04510; 
hsa04910; 
hsa05210; 
hsa05212; 
hsa05218; 
MAPK signaling pathway;  
Focal adhesion;  
Insulin signaling pathway;  
Colorectal cancer;  
Pancreatic cancer;  
Melanoma;  
2/5 0.0293; 
0.0174; 
0.00925; 
0.00422; 
0.00327; 
0.00322; 
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hsa05220 Chronic myeloid leukemia 0.0035 
TEF hsa04010 MAPK signaling pathway 3/7 0.00662 
HLF hsa04010 MAPK signaling pathway 2/8 0.0705 
KCNQ2 hsa04080 Neuroactive ligand-receptor interaction 2/17 0.279 
NID hsa04512 ECM-receptor interaction 2/3 0.00169 
IRS1 hsa04510 Focal adhesion 8/21 7.37E-06 
CBL hsa04650 Natural killer cell mediated cytotoxicity 17/62 2.09E-10 
RALGDS hsa04670 Leukocyte transendothelial migration 2/5 0.00713 
TRAF3IP2 hsa04010; 
hsa04210; 
hsa04660; 
hsa05120 
MAPK signaling pathway;  
Apoptosis;  
T cell receptor signaling pathway;  
Epithelial cell signaling in Helicobacter pylori 
infection 
2/8 0.0705; 
0.0105; 
0.0143; 
0.00677 
LILRB1 hsa04612 Antigen processing and presentation 2/3 0.0018 
NOG hsa04060 Cytokine-cytokine receptor interaction 2/3 0.0109 
CDC25B hsa04910 Insulin signaling pathway 4/13 0.000868 
CDH2 hsa04520; 
hsa05130; 
hsa05131; 
hsa05216 
Adherens junction;  
Pathogenic Escherichia coli infection - EHEC;  
Pathogenic Escherichia coli infection - EPEC; 
Thyroid cancer 
2/3 0.00145; 
0.000851; 
NA; 
0.00036 
SKIL hsa04110 Cell cycle 3/8 0.00141 
GUCY1A2 hsa04020 Calcium signaling pathway 4/15 0.00281 
NFE2L1 hsa04010 MAPK signaling pathway 2/6 0.0414 
ZIC1 hsa04340 Hedgehog signaling pathway 3/3 1.09E-05 
ZIC2 hsa05217 Basal cell carcinoma 2/3 0.000896 
GMFB hsa04010 MAPK signaling pathway 6/6 3.44E-07 
STXBP6 hsa04130 SNARE interactions in vesicular transport 2/2 0.000219 
CCL3L1 hsa04060 Cytokine-cytokine receptor interaction 4/4 4.85E-05 
Rasd2
¶
 mmu05212 Pancreatic cancer 4/24 NA 
Rps27a
¶
 mmu04620 Toll-like receptor signaling pathway 2/15 NA 
Sqstm1
¶
 mmu04010; 
mmu04810 
MAPK signaling pathway; Regulation of actin 
cytoskeleton 
2/13 NA; 
NA 
Map2k3
¶
 mmu04810; 
mmu05212 
Regulation of actin cytoskeleton; Pancreatic 
cancer 
2/13 NA; 
NA 
Uhmk1
¶
 mmu04620 Toll-like receptor signaling pathway 2/15 NA 
Rhod
¶
 mmu04010; 
mmu04620 
MAPK signaling pathway;  
Toll-like receptor signaling pathway 
2/15 NA; 
NA 
CCDC5 hsa04110 Cell cycle 5/6 4.91E-07 
     
Protein GO ID GO Term Ratio P value 
APP GO:0005509 calcium ion binding 4/9 0.00148 
DLG4 GO:0004385 guanylate kinase activity 4/11 1.13E-09 
NCOA1 GO:0008270 zinc ion binding 13/38 0.00148 
KHDRBS1 GO:0005524 ATP binding 5/18 0.0151 
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RELA GO:0008270 zinc ion binding 11/31 0.00239 
PTPN11 GO:0005524 ATP binding 16/50 5.53E-06 
GHR GO:0005524 ATP binding 14/33 6.30E-07 
IL2RB GO:0005524 ATP binding 8/17 7.44E-05 
JUN GO:0008270 zinc ion binding 12/35 0.00217 
SAA1 GO:0005509 calcium ion binding 4/11 0.00307 
CD19 GO:0005524 ATP binding 4/10 0.00839 
CD22 GO:0005524 ATP binding 9/23 0.000133 
PIK3R1 GO:0005524 ATP binding 21/66 2.50E-07 
PTPN6 GO:0005524 ATP binding 11/35 0.000201 
TRAF1 GO:0005524; 
GO:0043123 
ATP binding;  
positive regulation of I-kappaB 
kinase/NF-kappaB cascade 
4/10 0.00839; 
7.74e-07 
PTPN1 GO:0005159 insulin-like growth factor receptor binding 4/14 4.29E-09 
GRB2 GO:0005524 ATP binding 23/61 2.24E-09 
BLNK GO:0005070 SH3/SH2 adaptor activity 4/15 4.29E-07 
IRS2 GO:0005524 ATP binding 7/27 0.00746 
EPOR GO:0005524 ATP binding 12/38 9.70E-05 
GAB2 GO:0005070; 
GO:0005524 
SH3/SH2 adaptor activity;  
ATP binding 
6/34 5.44e-09; 
0.0587 
PTPN12 GO:0005524 ATP binding 7/15 0.000228 
PTPRC GO:0005524 ATP binding 4/15 0.0317 
CD2AP GO:0005524 ATP binding 4/10 0.00839 
VAV1 GO:0005524 ATP binding 14/43 1.63E-05 
PAG1 GO:0005524 ATP binding 10/45 0.00495 
CD28 GO:0005070 SH3/SH2 adaptor activity 4/12 1.72E-07 
RAPGEF1 GO:0005524 ATP binding 5/10 0.00144 
GAB3 GO:0005524 ATP binding 6/21 0.0079 
TUB GO:0005524 ATP binding 4/8 0.00402 
SOS1 GO:0005524 ATP binding 6/19 0.00501 
PLCG1 GO:0005524 ATP binding 13/49 0.000309 
BCAR1 GO:0005524 ATP binding 6/28 0.0266 
RASA1 GO:0005524 ATP binding 6/22 0.00938 
SOCS1 GO:0005524 ATP binding 6/23 0.0115 
VAV3 GO:0005524 ATP binding 5/17 0.0122 
SHB GO:0005524 ATP binding 7/25 0.00501 
CRK GO:0005524 ATP binding 4/13 0.0198 
BCR GO:0005524 ATP binding 6/17 0.00307 
TBP GO:0008270 zinc ion binding 7/20 0.0125 
REM1 GO:0005524 ATP binding 4/11 0.0116 
RBBP4 GO:0008270 zinc ion binding 7/17 0.00555 
RICS GO:0005524 ATP binding 5/15 0.00784 
GNAI1 GO:0003924 GTPase activity 4/4 9.45E-08 
FOS GO:0008270 zinc ion binding 6/19 0.0313 
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PECAM1 GO:0005524 ATP binding 9/26 0.00036 
FN1 GO:0005509 calcium ion binding 6/18 0.000478 
RB1 GO:0008270 zinc ion binding 6/16 0.0144 
GADD45G GO:0030521 androgen receptor signaling pathway 4/8 1.22E-08 
MCM10 GO:0008270 zinc ion binding 10/26 0.00206 
ORC2L GO:0005524 ATP binding 8/11 1.25E-06 
ASK GO:0005524 ATP binding 6/8 2.24E-05 
GTF2H1 GO:0005524 ATP binding 4/9 0.00602 
HDAC1 GO:0008270 zinc ion binding 8/24 0.011 
PXN GO:0005524 ATP binding 5/16 0.00966 
DCN GO:0005509 calcium ion binding 5/15 0.00148 
TGFBI GO:0005509 calcium ion binding 4/13 0.00523 
OSM GO:0005509 calcium ion binding 4/12 0.00402 
ANTXR2 GO:0005509 calcium ion binding 4/10 0.00221 
HABP2 GO:0005509 calcium ion binding 4/12 0.00402 
COL1A1 GO:0005587 collagen type IV 6/12 8.49E-16 
COL1A2 GO:0005587 collagen type IV 6/9 1.16E-16 
POU2F1 GO:0008270 zinc ion binding 5/14 0.0296 
FAS GO:0043123 positive regulation of I-kappaB 
kinase/NF-kappaB cascade 
5/6 6.74E-10 
CASP10 GO:0043123 positive regulation of I-kappaB 
kinase/NF-kappaB cascade 
4/6 8.47E-08 
TIF1 GO:0003714 transcription corepressor activity 4/12 5.50E-06 
SHC1 GO:0005524 ATP binding 16/50 5.53E-06 
SOCS3 GO:0005159 insulin-like growth factor receptor binding 4/10 1.17E-09 
IL4R GO:0005524; 
GO:0043560 
ATP binding;  
insulin receptor substrate binding 
4/12 0.0151; 
9.39e-10 
PIK3R2 GO:0005524 ATP binding 4/10 0.00839 
LCP2 GO:0005524 ATP binding 7/25 0.00501 
GTF2E2 GO:0005524 ATP binding 6/9 6.09E-05 
CRKL GO:0005524 ATP binding 16/43 6.86E-07 
HDAC3 GO:0008270 zinc ion binding 5/16 0.0494 
SERPINE2 GO:0005509 calcium ion binding 4/12 0.00402 
ARID4A GO:0008270 zinc ion binding 4/5 0.00239 
TNFAIP3 GO:0005524 ATP binding 7/15 0.000228 
KCNJ12 GO:0005509; 
GO:0005524 
calcium ion binding;  
ATP binding 
5/17 0.00248; 
0.0122 
MAP3K14 GO:0043123 positive regulation of I-kappaB 
kinase/NF-kappaB cascade 
7/17 8.18E-11 
SIN3A GO:0003714; 
GO:0008270 
transcription corepressor activity;  
zinc ion binding 
4/16 1.57e-05; 
0.146 
NCOA2 GO:0008270; 
GO:0030521 
zinc ion binding; 
 androgen receptor signaling pathway 
5/12 0.0151; 
7.33e-10 
AHR GO:0008270 zinc ion binding 7/13 0.00118 
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PPARBP GO:0008270 zinc ion binding 9/23 0.00285 
KCNJ4 GO:0000287; 
GO:0005509 
magnesium ion binding;  
calcium ion binding 
4/10 0.000201; 
0.00221 
CRIPT GO:0005509 calcium ion binding 4/14 0.00678 
CDC45L GO:0005524 ATP binding 4/8 0.00402 
ORC3L GO:0005524 ATP binding 4/5 0.000483 
HDAC9 GO:0008270 zinc ion binding 5/12 0.0151 
NR0B2 GO:0030521; 
GO:0050681 
androgen receptor signaling pathway; 
androgen receptor binding 
4/10 3.44e-08; 
1.02e-08 
USP7 GO:0043123 positive regulation of I-kappaB 
kinase/NF-kappaB cascade 
4/15 4.29E-06 
TNFRSF19 GO:0043123 positive regulation of I-kappaB 
kinase/NF-kappaB cascade 
4/19 1.00E-05 
ACTR2 GO:0005885 Arp2/3 protein complex 6/6 5.13E-18 
RIBC2 GO:0008270 zinc ion binding 4/14 0.101 
FLJ32855 GO:0008270 zinc ion binding 6/19 0.0313 
TU3A GO:0008270 zinc ion binding 9/27 0.00784 
UTP14A GO:0008270 zinc ion binding 4/7 0.00937 
C1orf65 GO:0008270 zinc ion binding 4/8 0.0151 
WAS GO:0005524 ATP binding 7/23 0.00333 
IRS1 GO:0005524 ATP binding 8/21 0.000381 
CBL GO:0005524 ATP binding 18/62 6.08E-06 
TNFRSF17 GO:0005031 tumor necrosis factor receptor activity 4/11 7.33E-10 
ATP2B4 GO:0030955 potassium ion binding 4/16 1.52E-05 
TRAF3IP2 GO:0005524 ATP binding 4/8 0.00402 
CDC25B GO:0005524 ATP binding 4/13 0.0198 
GUCY1A2 GO:0005509 calcium ion binding 4/15 0.00838 
TNFRSF8 GO:0005031 tumor necrosis factor receptor activity 4/14 1.38E-09 
TNFRSF11
A 
GO:0005524; 
GO:0043123 
ATP binding;  
positive regulation of I-kappaB 
kinase/NF-kappaB cascade 
4/17 0.0481; 
6.39e-06 
Rps27a
¶
 GO:0005525 GTP binding 6/15 1.47E-06 
Fbxo3
¶
 GO:0005525 GTP binding 6/13 6.30E-07 
Sqstm1
¶
 GO:0005525 GTP binding 6/13 6.30E-07 
Map2k3
¶
 GO:0005525 GTP binding 5/13 1.45E-05 
Uhmk1
¶
 GO:0005525 GTP binding 6/15 1.47E-06 
KIAA1267 GO:0008270 zinc ion binding 4/15 0.123 
CCDC5 GO:0005524 ATP binding 4/6 0.00131 
 
¶
 indicates mouse proteins. 
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Appendix C 
Figure S1 The whole cluster that consists of 1,729 human proteins. Indices above protein 
names are their coordinates in this cluster. Fig. S1 was reproduced from REF. 76. 
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